Molekulargenetisches Labor der Pädiatrische Genetik
Informationen über unsere Leistungen und Methoden
Aktuelles Leistungsverzeichnis
Informationen zur weiteren Methoden unseres Labors
Anforderungen und Einwilligungen
Anforderung einer (Trio-) Exomsequenzierung und Einwilligung nach Gendiagnostikgesetz (GenDG)
Anforderung und Einwilligung nach dem GenDG zu einer molekulargenetischen Diagnostik
Anforderung molekulare Karyotypisierung postnatal und Einwilligung nach Gendiagnostikgesetz (GenDG)
Aufklärung und Einwilligung gemäß Gendiagnostikgesetz (GenDG)
Molekulargenetische Untersuchungen
GeneGen | Krankheit |
ABCC8+del | Diabetes mellitus, noninsulin-dependent |
Diabetes mellitus, permanent neonatal | |
Diabetes mellitus, transient neonatal 2 | |
Hyperinsulinemic hypoglycemia, familial, 1 | |
Hypoglycemia of infancy, leucine-sensitive | |
ACADM (=MCAD)+del | Acyl-CoA dehydrogenase medium chain deficiency (ACADM) |
ACADVL (=VLCAD) | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) |
ACAN | Osteochondritis dissecans, short stature, and early-onset osteoarthritis (OD) |
Spondyloepimetaphyseal dysplasia (SEDM), aggrecan type | |
Spondyloepiphyseal dysplasia, Kimberley type (SEDK) | |
ACP5 | Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) |
ACTA2 | Aortic aneurysm, familial thoracic 6 (AAT6) |
Congenital mydriasis | |
Moyamoya disease 5 (MYMY5) | |
Multisystemic smooth muscle dysfunction syndrome | |
ACVR1 | Fibrodysplasia ossificans progressiva (FOP) |
ADAMTSL2 | Geleophysic dysplasia (GLPD) |
AGPAT2+del | Lipodystrophy, congenital generalized, type 1 (CGL1) |
AKT1 | Breast cancer, somatic (BC) |
Colorectal cancer, somatic (CRC) (= Colon cancer) | |
Ovarian cancer, somatic (OC) | |
Proteus syndrome, somatic (PROTEUSS) | |
Schizophrenia, susceptibility to | |
ALDOB+del | Fructose intolerance, hereditary (HFI) |
ALPL (=TNSALP)+del | Hypophosphatasia (HOPS), adult, childhood, infantile or perinatal lethal |
Odontohypophosphatasia | |
ALX4+del | foramina parietalia permagna (FPP) |
frontonasal dysplasia type 2 (FND2) | |
parietal foramina 2 (PFM2) | |
Potocki-Shaffer syndrome (PSS) (= 11p11.2 deletion syndrome) | |
ANTXR1 (=TEM8) | Hemangioma, capillary infantile, susceptibility to (HCI) |
ANTXR2 (=CMG2) | infantile systemic hyalinosis (ISH) |
juvenile hyaline fibromatosis (JHF) | |
APC+del+dup | Adenoma, periampullary, somatic |
Adenomatous polyposis coli, familial (FAP) | |
Brain tumor-polyposis syndrome 2 (Gardner syndrome (GS)) | |
Colorectal cancer, somatic (CRC) | |
Desmoid disease, hereditary (HDD) | |
Gastric cancer, somatic | |
Hepatoblastoma, somatic | |
Medulloblastoma (MDB), somatic | |
APOC2+del | Apolipoprotein C-II deficiency |
ARSE+del | X-linked recessive chondrodysplasia punctata type 1 (CPXR1) |
ARTEMIS (offiz. DCLRE1C)+del | Omenn syndrome (Reticuloendotheliosis, familial, with eosinophilia) |
severe combined immunodeficiency Athabaskan-type (SCIDA) | |
severe combined immunodeficiency with sensitivity to ionizing radiation (RS-SCID) | |
ARX+del+dup | Corpus callosum, agenesis of (ACC), with abnormal genitalia (Proud syndrome) |
Epileptic encephalopathy, early infantile, 1 (EIEE1) (West syndrome, X-linked) | |
Hydranencephaly with abnormal genitalia | |
Lissencephaly, X-linked 2 (LISX2) (Lissencephaly, X-linked, with ambiguous genitalia (XLAG)) | |
Mental retardation, X-linked, with or without seizures, ARX-related (MRXARX) | |
Partington X-linked mental retardation syndrome (PRTS) | |
ATL1+del | Neuropathy, hereditary sensory, type ID (HSN1D) |
Spastic paraplegia-3A (SPG3A) (Strumpell-Lorrain syndrome) | |
ATP6V0A2+del | Cutis laxa, autosomal recessive, type IIA (ARCL2A) |
Wrinkly skin syndrome (WSS) | |
ATP7A+del+dup | Menkes disease (= Kinky hair disease) |
Occipital horn syndrome (OHS) | |
Spinal muscular atrophy, distal, X-linked 3 (SMAX3) | |
ATRX+del+dup | Alpha-thalassemia myelodysplasia syndrome (ATMDS) |
Alpha-thalassemia/mental retardation syndrome, X-linked (ATRX) | |
Mental retardation-hypotonic facies syndrome, X-linked (MRXHF1) |
Gen | Krankheit |
B3GALT6 | Ehlers-Danlos syndrome, progeroid type, 2 (EDSP2) |
Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures (SEMDJL1) | |
B3GALTL+del | Peters-plus syndrome (PpS) |
B4GALT7 | Ehlers-Danlos syndrome, progeroid form (EDSP) |
BARX2 | Role in chondrogenesis, myoblast fusion, ocular gland branching, muscle growth and regeneration |
BCOR+del | Microphthalmia, syndromic 1 (MCOPS1) |
BCOR+del | Microphthalmia, syndromic 2 (MCOPS2) |
BMP1 | Osteogenesis imperfecta,autosomal recessive |
BMP2+del+dup | Brachydactyly, type A2 (BDA2) |
HFE hemochromatosis, modifier of | |
BMP4 | Congenital 'healed' cleft lip (CHCL) |
Microphthalmia, syndromic 6 (MCOPS6) | |
orofacial cleft type 11 (OFC11) | |
BMPR1A+del | Juvenile polyposis of stomach |
Juvenile polyposis syndrome (JPS) | |
Polyposis syndrome, hereditary mixed, 2 (HMPS2) | |
BMPR1Adel | Chromosome 10q23 deletion syndrome |
Juvenile polyposis of infancy | |
BMPR1B | acromesomelic chondrodysplasia with genital anomalies (AMDGA) |
brachydactyly, type A2 (BDA2) | |
BRAF | Adenocarcinoma of lung, somatic |
Cardiofaciocutaneous syndrome (CFC syndrome) | |
Colorectal cancer, somatic (CRC) | |
LEOPARD syndrome 3 | |
Melanoma, malignant, somatic | |
Nonsmall cell lung cancer, somatic | |
Noonan syndrome 7 | |
BSCL2+del | Lipodystrophy, congenital generalized, type 2 (CGL2) (Berardinelli-Seip congenital lipodystrophy, type 2) |
Neuronopathy, distal hereditary motor, type VA (HMN5A) | |
Spastic paraplegia 17, autosomal dominant (SPG17) (Silver snydrome) |
Gen | Krankheit |
C1NH (offiz. SERPING1)+del | Angioedema, hereditary, type I (HAE1) (C1 esterase inhibitor, deficiency of) |
Angioedema, hereditary, type II (HAE2) | |
Complement component 4 (C4), partial deficiency of | |
C6ST1 (offiz. CHST3) | Larsen syndrome, autosomal recessive |
Spondyloepiphyseal dysplasia with congenital joint dislocations (SED Omani type) | |
C7orf10 | Glutaric aciduria III (GA3) (Glutaryl-CoA oxidase deficiency) |
C8B | Complement component 8 deficiency, type II (C8D2) |
C16orf57 (offiz. USB1) | Poikiloderma with neutropenia (PN) (Poikiloderma with neutropenia, Clericuzio-type) |
CANT1+del | Desbuquois dysplasia (DBQD) |
CAV1 | Lipodystrophy, congenital generalized, type 3 (CGL3) (Berardinelli-Seip congenital lipodystrophy, type 3) |
Pulmonary hypertension, primary, 3 (PPH3) | |
CBL | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSL) |
CCDC8 | 3M syndrome-3 (3M3) |
CD96 | C syndrome (CSYN) (Opitz trigonocephaly syndrome) |
C-like syndrome (CLSYN) (Opitz trigonocephaly-like syndrome) | |
CDK1 (=CDC2) | Schlüsselrolle bei der Zellzyklus-Kontrolle |
CDKL5+del+dup | Angelman syndrome-like |
Epileptic encephalopathy, early infantile, 2 (EIEE2) (Rett syndrome, atypical, CDKL5-related) | |
CDKN1C+dup | Beckwith-Wiedemann syndrome (BWS) |
IMAGE (Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies) syndrome | |
CDMP1 (offiz. GDF5) | Acromesomelic dysplasia, Hunter-Thompson type (AMDH) |
Brachydactyly, type A2 (BDA2) (=Brachymesophalangy II) | |
Brachydactyly, type C (BDC) (Brachydactyly, Haws type) | |
Chondrodysplasia, Grebe type | |
Fibular hypoplasia and complex brachydactyly (Du Pan syndrome (DPS)) | |
Multiple synostoses syndrome 2 (SYNS2) | |
Osteoarthritis susceptibility 5 (OS5) | |
Symphalangism, proximal (SYM1) (Cushing symphalangism) | |
CEBPA | Leukemia, acute myeloid |
CEP19 | Obesity, morbide |
CGKI (offiz. PRKG1) | nitric oxide/cGMP signaling pathway, key mediators |
signal transduction processes in diverse cell types, important components | |
CHD7 (=KAL5)+del | CHARGE syndrome |
hypogonadotropic hypogonadism, idiopathic (IHH) | |
idiopathic scoliosis 3, susceptibility to (IS3) | |
Kallmann syndrome 5 (KAL5) | |
CHRNA3 | Lung cancer susceptibility 2 (LNCR2) |
Smoking as a quantitative trait locus 3 (SQTL3) | |
CHST10 | Rolle in der HNK1-Biosynthese (neurodevelopment and synaptic plasticity) |
CHST11 | Sulfatstoffwechsel |
CHST12 | Sulfatstoffwechsel |
CHST3 (=C6ST1) | Larsen syndrome, autosomal recessive |
Spondyloepiphyseal dysplasia with congenital joint dislocations (= SED Omani type) | |
CMG2 (offiziell ANTXR2) | infantile systemic hyalinosis (ISH) |
juvenile hyaline fibromatosis (JHF) | |
C-MLP (offiz. MLP) | Myelofibrosis with myeloid metaplasia, somatic (MMM) |
Thrombocythemia 2 (THCYT2) | |
Thrombocytopenia, congenital amegakaryocytic (CAMT) | |
COL1A1+del | Caffey disease (CAFFD) (infantile cortical hyperostosis) |
Ehlers-Danlos syndrome type I (EDS1) (Ehlers-Danlos syndrome gravis) | |
Ehlers-Danlos syndrome type VIIA (EDS7A) (EDS, arthrochalasia type) | |
Osteogenesis imperfecta type I (OI1) (OI tarda, OI with blue sclerae) | |
Osteogenesis imperfecta type IIA (OI2A) (OI congenita, perinathal lethal form) | |
Osteogenesis imperfecta type III (OI3) (OI, progressively deforming, with normal sclerae) | |
Osteogenesis imperfecta type IV (OI4) (OI with normal sclerae) | |
Osteoporosis, susceptibility to (OSTEOP) | |
COL1A2+del | Ehlers-Danlos syndrome, cardiac valvular form (EDSCV) |
Ehlers-Danlos syndrome, type VIIB (EDS7B) (EDS, arthrochalasia type) | |
Marfan syndrome, atypical | |
Osteogenesis imperfecta type IIA (OI2A) (OI congenita, perinathal lethal form) | |
Osteogenesis imperfecta type III (OI3) (OI, progressively deforming, with normal sclerae) | |
Osteogenesis imperfecta type IV (OI4) (OI with normal sclerae) | |
Osteoporosis, postmenopausal | |
COL2A1+del | Achondrogenesis type II (ACG2) (ACG, Langer-Saldino type) |
Avascular necrosis of the femoral head (ANFH) | |
Czech dysplasia (pseudorheumatoid dysplasia, progressive, with hypoplastic toes) | |
Epiphyseal dysplasia, multiple, with myopia and deafness (EDMMD) | |
Hypochondrogenesis | |
Kniest dysplasia (KD) | |
Legg-Calve-Perthes disease (LCPD; LCP) | |
Osteoarthritis with mild chondrodysplasia (OACD) | |
Otospondylomegaepiphyseal dysplasia (OSMED) (Nance-Sweeney chondrodysplasia) | |
Platyspondylic lethal skeletal dysplasia, Luton type (PLSD-L) | |
Platyspondylic skeletal dysplasia, Torrance type (PLSD-T) | |
rhegmatogenous retinal detachment, autosomal dominant (DRRD) | |
SED, Namaqualand type | |
Spondyloepimetaphyseal dysplasia, Strudwick type (SEMD-STR) | |
Spondyloepiphyseal dysplasia congenita (SEDC) | |
Spondyloperipheral dysplasia (SPD) | |
Stickler sydrome, type I, nonsyndromic ocular (STL1O) | |
Stickler syndrome, type I (STL1) (Stickler syndrome, vitreous type 1) | |
Vitreoretinopathy with phalangeal epiphyseal dysplasia | |
Wagner syndrome type 2 (WGN2) | |
COL3A1+del | aortic aneurysm, familial abdominal 1 (AAA1) |
Ehlers-Danlos syndrome, type III (EDSIII; EDS3) (EDS, hypermobility type) | |
Ehlers-Danlos syndrome, type IV, autosomal dominant (EDS IV; EDS4) (EDS, vascular type) | |
COL4A1 | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps (HANAC) |
Brain small vessel disease with Axenfeld-Rieger anomaly | |
Brain small vessel disease with hemorrhage (BSVDH) (infantile hemiparesis) | |
Porencephaly, familial (PCEPH) | |
COL4A2 | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps (HANAC) |
Brain small vessel disease with Axenfeld-Rieger anomaly | |
Brain small vessel disease with hemorrhage (BSVDH) (infantile hemiparesis) | |
COL4A3 | Alport syndrome, autosomal dominant (APSAD) |
Alport syndrome, autosomal recessive (APSAR) | |
Hematuria, benign familial (BFH) (Thin-basement-mambrane nephropathy) | |
COL4A4 | Alport syndrome, autosomal recessive |
Hematuria, benign familial (BFH) (=Thin-basement-membrane nephropathy) | |
COL4A5+del | Alport syndrome X-linked (APSX) |
Leiomatosis, diffuse, with Alport syndrome (DL-ATS) | |
COL5A1+del+dup | Ehlers-Danlos syndrome, type I (EDS I) (EDS1) (EDS, severe classic type) |
Ehlers-Danlos syndrome, type II (EDS II) (EDS2) (EDS, mild classic type) | |
COL5A2 | Ehlers-Danlos syndrome, type I (EDS I) (EDS1) (EDS, severe classic type) |
COL9A1 | epiphyseal dysplasia, multiple, type 6 (EDM6) |
Stickler Syndrome, autosomal recessive, COL9A1-related (COL9A1ARSTL) | |
COL9A2 | Epiphyseal dysplasia, multiple, 2 (EDM2) |
Intervertebral disc disease (IDD), susceptibility to | |
Stickler syndrome, type V (STL5) | |
COL9A3 | Epiphyseal dysplasia, multiple, 3 (EDM3) |
Epiphyseal dysplasia, multiple, with myopathy | |
Hearing loss, non-syndromic | |
Intervertebral disc disease, susceptibility to | |
Pseudoachondroplasia (PSACH) | |
COL10A1 | Metaphyseal chondrodysplasia, Schmid type (MCDS) |
COL11A1+del | Fibrochondrogenesis |
Lumbar disc herniation, susceptibility to | |
Marshall syndrome (MARSHS) | |
Stickler syndrome, type II (STL2) | |
Stickler syndrome, vitreous type 2 | |
COL11A2 | deafness, autosomal dominant type 13 (DFNA13) |
deafness, autosomal recessive type 53 (DFNB53) | |
OSMED, heterozygous (WZS) | |
Otospondylomegaepiphyseal dysplasia (OSMED) | |
Stickler syndrome, type III (STL3) | |
Weissenbacher-Zweymueller syndrome (WZS) | |
COMP+del | Epiphyseal dysplasia, Fairbank type (EDMF) |
Epiphyseal dysplasia, multiple 1 (EDM1) | |
Epiphyseal dysplasia, Ribbing type (EDMR) | |
Pseudoachondroplasia (PSACH) | |
CPT2 | CPT deficiency, hepatic, type II (Carnitine palmitoyltransferase II deficiency, infantile) |
CPT II deficiency, lethal neonatal (Carnitine palmitoyltransferase 2 deficiency, lethal neonatal) | |
CPT II deficiency, myopathic (Carnitine palmitoyltransferase 2 deficiency, late-onset) | |
Encephalopathy, acute, infection-induced, 4, susceptibility to (IIAE4) | |
CPX (offiz. EBP) | Chondrodysplasia punctata, X-linked dominant, 2 (CDPX2) (Conradi-Hunermann-Happle syndrome) |
CREB3L2 | chondrocyte differentiation, key role in |
epiphyseal cartilage, key role in formation of | |
Fibromyxoid sarcoma, low grade (LGFMS) | |
transcription of unfolded protein response target genes, regulation of | |
CREBBP+del | 16p13.3 deletion syndrome |
leukemia, acute myeloid | |
Rubinstein-Taybi syndrome type 1 (RSTS1) | |
CRELD1 | Atrioventricular septal defect, partial, with heterotaxy syndrome |
Atrioventricular septal defect, susceptibility to, 2 (AVSD2) | |
CRTAP | Osteogenesis imperfecta, type IIB (OI2B) |
Osteogenesis imperfecta, type VII (OI7) | |
CSGALNACT1+del | role in enchondral ossification and aggrecan metabolism; required for normal cartilage development |
CTC1 | Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) (Coats plus syndrome) |
CTNNB1 | Adenomas, salivary gland pleomorphic (PSA) |
Colorectal cancer (CRC) | |
Hepatoblastoma | |
Hepatocellular carcinoma (HCC) | |
Medulloblastoma (MDB) | |
Mesothelioma, malignant; susceptibility to (MESOM) | |
Ovarian cancer (OC) | |
Pilomatricoma (PTR) | |
CTSK | Pycnodysostosis (PKND) |
CUL7 | 3-M syndrome 1 (3M1) |
CX26 (offiz. GJB2) | Bart-Pumphrey syndrome (BPS) |
Deafness, autosomal dominant 3A (DFNA3A) | |
Deafness, autosomal recessive 1A (DFNB1A) | |
Hystrix-like ichthyosis with deafness (HID syndrome) | |
Keratitis-ichthyosis-deafness syndrome (KID syndrome) | |
Keratoderma, palmoplantar, with deafness (PPKDFN) | |
Vohwinkel syndrome (VS) | |
CXCR4 | Myelokathexis, isolated |
WHIM (Warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome | |
CYP7B1 | Bile acid synthesis defect, congenital, 3 (CBAS3) |
Spastic paraplegia 5A, autosomal recessive (SPG5A) |
Gen | Krankheit |
D2HGDH+del | D-2-Hydroxyglutaric aciduria 1 (D2HGA) (D2HGA1) |
DBP+del (offiz. HSD17B4) | D-bifunctional protein deficiency (DBPD) |
Perrault syndrome (PRS) | |
DCLRE1C(=ARTEMIS)+del | Omenn syndrome (Reticuloendotheliosis, familial, with eosinophilia) |
severe combined immunodeficiency Athabaskan-type (SCIDA) | |
severe combined immunodeficiency with sensitivity to ionizing radiation (RS-SCID) | |
DHCR7+del | Smith-Lemli-Opitz syndrome (SLOS) |
DKC1 | Dyskeratosis congenita, X-linked |
DLD (=LAD) | Dihydrolipoamide dehydrogenase deficiency (DLDD) (Maple syrup urine disease, type III) |
DLL3 | Spondylocostal dysostosis, autosomal recessive, 1 (SCDO1) |
DNASE2 | apoptosis, major role during |
erythropoiesis, major role during | |
DNMT3B | Immunodeficiency-centromeric instability-facial anomalies syndrome (ICF1) |
DTDST (offiziell SLC26A2) | Achondrogenesis Ib (ACG1B) |
Atelosteogenesis II (AO2) | |
De la Chapelle dysplasia (DLCD) | |
Diastrophic dysplasia (DTD) | |
Diastrophic dysplasia, broad bone-platyspondylic variant (DTDB) | |
Epiphyseal dysplasia, multiple, 4 (EDM4) | |
DYM+dup | Dyggve-Melchior-Clausen disease (DMC) |
Smith-McCort dysplasia (SMC) | |
DYNC2H1 | Asphyxiating thoracic dystrophy 3 (ATD3) |
Short rib-polydactyly syndrome, type II, digenic (SRPS2) | |
Short rib-polydactyly syndrome, type III (SRPS3) (Verma-Naumoff syndrome) | |
EBP (=CPX) | Chondrodysplasia punctata, X-linked dominant, 2 (CDPX2) (Conradi-Hunermann-Happle syndrome) |
ECSIT | Complex I deficiency, mitochondrial |
EDN3 | Central hypoventilation syndrome, congenital (CCHS) (Ondine curse) |
Hirschsprung disease, susceptibility to, 4 (HSCR4) (aganglionic megacolon (MGC)) | |
Waardenburg syndrome, type 4B (WS4B) (WS4B with Hirschsprung disease) | |
EFNB1+del+dup | Craniofrontonasal syndrome (CFNS) |
ELN+del | Cutis laxa, autosomal dominant, 1 (ADCL1) |
Supravalvar aortic stenosis (SVAS) (SVAS, Eisenberg type) | |
ELNdel | Williams-Beuren syndrome (WBS) |
EP300+del | Colorectal cancer (CRC) |
Rubinstein-Taybi syndrome 2 (RSTS2) | |
ERCC3 (=XPB) | Ichthyosiform erythroderma with hair abnormality and mental and growth retardation |
Trichothiodystrophy, photosensitive (TTDP) | |
Xeroderma pigmentosum, group B (XBP) | |
Xeroderma pigmentosum/Cockayne syndrome (XPB/CS) | |
ETFA+del | Glutaric acidemia IIA (ETFA deficiency) |
Multiple acyl-CoA dehydrogenase deficiency (MADD) (Glutaric acidemia IIA) | |
ETFB | Glutaric acidemia IIB (ETFB deficiency) |
Multiple acyl-CoA dehydrogenase deficiency (MADD) (Glutaric acidemia IIB) | |
ETFDH | Glutaric acidemia IIC (GA2C) (ETFDH deficiency) |
Multiple acyl-CoA dehydrogenase deficiency (MADD) (Glutaric acidemia IIC) | |
EVC (=EVC1)+del | Ellis-van Creveld syndrome (EVC) (chondroectodermal dysplasia) |
Weyers acrodental dysostosis (WAD) (Curry-Hall syndrome) | |
EVC2+del | Ellis-van Creveld syndrome (EVC) (chondroectodermal dysplasia) |
Weyers acrodental dysostosis (WAD) (Curry-Hall syndrome) | |
EXT1+del (=TRPS2) | Chondrosarcoma (CHDSA) |
Exostoses, multiple, type 1 (EXT1) (Osteochondromas, multiple) | |
Langer-Giedion syndrome (LGS) (Trichorhinophalangeal syndrome, type II (TRPS2)) | |
EXT2+del | Chondrosarcoma (CHDSA) |
Exostoses, multiple, type 2 (EXT 2) (= Osteochondromas, multiple) | |
Potocki-Shaffer syndrome (PSS) (11p11.2 Deletion Syndrome) | |
EZH2 | Weaver syndrome (WES) (Weaver-Smith syndrome (WSS)) |
FAM110B | tumor progression, may be involved in |
FBN1+del | Acromicric dysplasia (ACMICD) |
Aortic aneurysm, ascending, and dissection | |
Ectopia lentis, familial (EL) | |
Geleophysic dysplasia 2 (GPHYSD2) | |
Marfan syndrome (MFS) (Marfan syndrome, type 1 (MFS1)) | |
MASS syndrome (overlap connective tissue disease (OCTD)) | |
Stiff skin syndrome (SSKS) | |
Weill-Marchesani syndrome 2 (WMS2) | |
FBN2 | Arthrogryposis, distal, type 9 (DA9) (Beals syndrome) |
FBXW8 | 3-M syndrome, candidate |
FGD1+del | Aarskog-Scott syndrome (AAS) (Faciogenital dysplasia (FGDY)) |
Mental retardation, X-linked syndromic 16 (MRXS16) | |
FGF8 | Hypogonadotropic hypogonadism |
Kallmann syndrome 6 (KAL6) | |
FGF9 | Multiple synostoses syndrome 3 (SYNS3) |
FGF10+del | Aplasia of lacrimal and salivary glands (ALSG) |
LADD (Lacrimoauriculodentodigital) syndrome (LADDS) (Levy-Hollister syndrome) | |
FGF17 | embryonic development, important role in the regulation of; embryonic brain, signaling molecule in the induction and patterning of the |
FGF23 | Hypophosphatemic rickets, autosomal dominant (ADHR) (Vitamin D-resistant rickets, AD) |
Osteomalacia, tumor-induced | |
Tumoral calcinosis, hyperphosphatemic, familial HFTC) (Morbus Teutschlaender) | |
FGFR1+del (=KAL2) | Hypogonadotropic hypogonadism |
Jackson-Weiss syndrome (JWS) (craniosynostosis, midfacial hypoplasia, and foot anomalies) | |
Kallmann syndrome 2 (KAL2) | |
Osteoglophonic dysplasia (OGD) | |
Pfeiffer syndrome (PS) (Acrocephalosyndactyly, type V ( ACS5)) | |
Trigonocephaly, nonsyndromic (TRICEPH) (Craniosynostosis, metopic) | |
FGFR2+del | Antley-Bixler syndrome, type 2 (ABS2) (ABS without genital anomalies or disordered steroidogenesis) |
Apert syndrome (APRS) (Acrocephalosyndactyly type 1 (ACS1)) | |
Beare-Stevenson cutis gyrata syndrome (BSTVS) | |
Craniofacial-skeletal-dermatologic dysplasia | |
Craniosynostosis, nonspecific | |
Crouzon syndrome (CS) (Craniofacial dysostosis type I (CFD1)) | |
Gastric cancer, somatic | |
Jackson-Weiss syndrome (JWS) (craniosynostosis, midfacial hypoplasia, and foot anomalies) | |
LADD (Lacrimoauriculodentodigital) syndrome (LADDS) (Levy-Hollister syndrome) | |
Pfeiffer syndrome (PS) (Acrocephalosyndactyly, type V ( ACS5)) | |
Saethre-Chotzen syndrome (SCS) (Acrocephalodyndactyly, type III ( ACS3)) | |
Scaphocephaly and Axenfeld-Rieger anomaly | |
Scaphocephaly, maxillary retrusion, and mental retardation | |
FGFR3 | Achondroplasia (ACH) |
Bladder cancer, somatic (BLC) | |
CATSHL (camptodactyly tall stature and hearing loss) syndrome | |
Cervical cancer, somatic (CERCA) | |
Crouzon syndrome with acanthosis nigricans | |
Hypochondroplasia | |
Keratosis, seborrheic, somatic | |
LADD (Lacrimoauriculodentodigital) syndrome (LADDS) (Levy-Hollister syndrome) | |
Muenke syndrome | |
multiple myeloma (MM) | |
Nevus, keratinocytic, nonepidermolytic (KNEN) | |
Spermatocytic seminoma, somatic | |
Thanatophoric dysplasia, type I (TD1) | |
Thanatophoric dysplasia, type II | |
FKBP10 | Osteogenesis imperfecta, type XI (OI11) |
FKBP14 | Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss (EDSKMH) |
FLI1 | Ewing sarcoma (ES) |
Hemangiomatosis | |
Leukemia, acute lymphoblastic | |
Paris-Trousseau thrombocytopenia (TCPT) | |
FLNB | Atelosteogenesis, type I (AOI) (Spondylohumerofemoral hypoplasia) |
Atelosteogenesis, type III (AOIII) (AO3) | |
Boomerang dysplasia | |
Larsen syndrome (LRS), autosomal dominant | |
Spondylocarpotarsal synostosis syndrome (SCT) | |
FOXC2+del | Lymphedema, hereditary, type 2 (LMPH2) (Meige disease) |
Lymphedema-distichiasis syndrome (LYDS) | |
Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus | |
Yellow nail syndrome (YNS) (Lymphedema and yellow nails (LYYN)) | |
FOXG1+del | Rett syndrome, congenital variant (RTTCV) |
FOXI1 | Enlarged vestibular aqueduct (EVA) |
Pendred syndrome (PDS) | |
FOXL2+del+dup | Blepharophimosis, epicanthus inversus, and ptosis, type 1 (BPES1) |
Blepharophimosis, epicanthus inversus, and ptosis, type 2 (BPES2) | |
Premature ovarian failure 3 |
Gen | Krankheit |
D2HGDH+del | D-2-Hydroxyglutaric aciduria 1 (D2HGA) (D2HGA1) |
DBP+del (offiz. HSD17B4) | D-bifunctional protein deficiency (DBPD) |
Perrault syndrome (PRS) | |
DCLRE1C(=ARTEMIS)+del | Omenn syndrome (Reticuloendotheliosis, familial, with eosinophilia) |
severe combined immunodeficiency Athabaskan-type (SCIDA) | |
severe combined immunodeficiency with sensitivity to ionizing radiation (RS-SCID) | |
DHCR7+del | Smith-Lemli-Opitz syndrome (SLOS) |
DKC1 | Dyskeratosis congenita, X-linked |
DLD (=LAD) | Dihydrolipoamide dehydrogenase deficiency (DLDD) (Maple syrup urine disease, type III) |
DLL3 | Spondylocostal dysostosis, autosomal recessive, 1 (SCDO1) |
DNASE2 | apoptosis, major role during |
erythropoiesis, major role during | |
DNMT3B | Immunodeficiency-centromeric instability-facial anomalies syndrome (ICF1) |
DTDST (offiziell SLC26A2) | Achondrogenesis Ib (ACG1B) |
Atelosteogenesis II (AO2) | |
De la Chapelle dysplasia (DLCD) | |
Diastrophic dysplasia (DTD) | |
Diastrophic dysplasia, broad bone-platyspondylic variant (DTDB) | |
Epiphyseal dysplasia, multiple, 4 (EDM4) | |
DYM+dup | Dyggve-Melchior-Clausen disease (DMC) |
Smith-McCort dysplasia (SMC) | |
DYNC2H1 | Asphyxiating thoracic dystrophy 3 (ATD3) |
Short rib-polydactyly syndrome, type II, digenic (SRPS2) | |
Short rib-polydactyly syndrome, type III (SRPS3) (Verma-Naumoff syndrome) | |
EBP (=CPX) | Chondrodysplasia punctata, X-linked dominant, 2 (CDPX2) (Conradi-Hunermann-Happle syndrome) |
ECSIT | Complex I deficiency, mitochondrial |
EDN3 | Central hypoventilation syndrome, congenital (CCHS) (Ondine curse) |
Hirschsprung disease, susceptibility to, 4 (HSCR4) (aganglionic megacolon (MGC)) | |
Waardenburg syndrome, type 4B (WS4B) (WS4B with Hirschsprung disease) | |
EFNB1+del+dup | Craniofrontonasal syndrome (CFNS) |
ELN+del | Cutis laxa, autosomal dominant, 1 (ADCL1) |
Supravalvar aortic stenosis (SVAS) (SVAS, Eisenberg type) | |
ELNdel | Williams-Beuren syndrome (WBS) |
EP300+del | Colorectal cancer (CRC) |
Rubinstein-Taybi syndrome 2 (RSTS2) | |
ERCC3 (=XPB) | Ichthyosiform erythroderma with hair abnormality and mental and growth retardation |
Trichothiodystrophy, photosensitive (TTDP) | |
Xeroderma pigmentosum, group B (XBP) | |
Xeroderma pigmentosum/Cockayne syndrome (XPB/CS) | |
ETFA+del | Glutaric acidemia IIA (ETFA deficiency) |
Multiple acyl-CoA dehydrogenase deficiency (MADD) (Glutaric acidemia IIA) | |
ETFB | Glutaric acidemia IIB (ETFB deficiency) |
Multiple acyl-CoA dehydrogenase deficiency (MADD) (Glutaric acidemia IIB) | |
ETFDH | Glutaric acidemia IIC (GA2C) (ETFDH deficiency) |
Multiple acyl-CoA dehydrogenase deficiency (MADD) (Glutaric acidemia IIC) | |
EVC (=EVC1)+del | Ellis-van Creveld syndrome (EVC) (chondroectodermal dysplasia) |
Weyers acrodental dysostosis (WAD) (Curry-Hall syndrome) | |
EVC2+del | Ellis-van Creveld syndrome (EVC) (chondroectodermal dysplasia) |
Weyers acrodental dysostosis (WAD) (Curry-Hall syndrome) | |
EXT1+del (=TRPS2) | Chondrosarcoma (CHDSA) |
Exostoses, multiple, type 1 (EXT1) (Osteochondromas, multiple) | |
Langer-Giedion syndrome (LGS) (Trichorhinophalangeal syndrome, type II (TRPS2)) | |
EXT2+del | Chondrosarcoma (CHDSA) |
Exostoses, multiple, type 2 (EXT 2) (= Osteochondromas, multiple) | |
Potocki-Shaffer syndrome (PSS) (11p11.2 Deletion Syndrome) | |
EZH2 | Weaver syndrome (WES) (Weaver-Smith syndrome (WSS)) |
FAM110B | tumor progression, may be involved in |
FBN1+del | Acromicric dysplasia (ACMICD) |
Aortic aneurysm, ascending, and dissection | |
Ectopia lentis, familial (EL) | |
Geleophysic dysplasia 2 (GPHYSD2) | |
Marfan syndrome (MFS) (Marfan syndrome, type 1 (MFS1)) | |
MASS syndrome (overlap connective tissue disease (OCTD)) | |
Stiff skin syndrome (SSKS) | |
Weill-Marchesani syndrome 2 (WMS2) | |
FBN2 | Arthrogryposis, distal, type 9 (DA9) (Beals syndrome) |
FBXW8 | 3-M syndrome, candidate |
FGD1+del | Aarskog-Scott syndrome (AAS) (Faciogenital dysplasia (FGDY)) |
Mental retardation, X-linked syndromic 16 (MRXS16) | |
FGF8 | Hypogonadotropic hypogonadism |
Kallmann syndrome 6 (KAL6) | |
FGF9 | Multiple synostoses syndrome 3 (SYNS3) |
FGF10+del | Aplasia of lacrimal and salivary glands (ALSG) |
LADD (Lacrimoauriculodentodigital) syndrome (LADDS) (Levy-Hollister syndrome) | |
FGF17 | embryonic development, important role in the regulation of; embryonic brain, signaling molecule in the induction and patterning of the |
FGF23 | Hypophosphatemic rickets, autosomal dominant (ADHR) (Vitamin D-resistant rickets, AD) |
Osteomalacia, tumor-induced | |
Tumoral calcinosis, hyperphosphatemic, familial HFTC) (Morbus Teutschlaender) | |
FGFR1+del (=KAL2) | Hypogonadotropic hypogonadism |
Jackson-Weiss syndrome (JWS) (craniosynostosis, midfacial hypoplasia, and foot anomalies) | |
Kallmann syndrome 2 (KAL2) | |
Osteoglophonic dysplasia (OGD) | |
Pfeiffer syndrome (PS) (Acrocephalosyndactyly, type V ( ACS5)) | |
Trigonocephaly, nonsyndromic (TRICEPH) (Craniosynostosis, metopic) | |
FGFR2+del | Antley-Bixler syndrome, type 2 (ABS2) (ABS without genital anomalies or disordered steroidogenesis) |
Apert syndrome (APRS) (Acrocephalosyndactyly type 1 (ACS1)) | |
Beare-Stevenson cutis gyrata syndrome (BSTVS) | |
Craniofacial-skeletal-dermatologic dysplasia | |
Craniosynostosis, nonspecific | |
Crouzon syndrome (CS) (Craniofacial dysostosis type I (CFD1)) | |
Gastric cancer, somatic | |
Jackson-Weiss syndrome (JWS) (craniosynostosis, midfacial hypoplasia, and foot anomalies) | |
LADD (Lacrimoauriculodentodigital) syndrome (LADDS) (Levy-Hollister syndrome) | |
Pfeiffer syndrome (PS) (Acrocephalosyndactyly, type V ( ACS5)) | |
Saethre-Chotzen syndrome (SCS) (Acrocephalodyndactyly, type III ( ACS3)) | |
Scaphocephaly and Axenfeld-Rieger anomaly | |
Scaphocephaly, maxillary retrusion, and mental retardation | |
FGFR3 | Achondroplasia (ACH) |
Bladder cancer, somatic (BLC) | |
CATSHL (camptodactyly tall stature and hearing loss) syndrome | |
Cervical cancer, somatic (CERCA) | |
Crouzon syndrome with acanthosis nigricans | |
Hypochondroplasia | |
Keratosis, seborrheic, somatic | |
LADD (Lacrimoauriculodentodigital) syndrome (LADDS) (Levy-Hollister syndrome) | |
Muenke syndrome | |
multiple myeloma (MM) | |
Nevus, keratinocytic, nonepidermolytic (KNEN) | |
Spermatocytic seminoma, somatic | |
Thanatophoric dysplasia, type I (TD1) | |
Thanatophoric dysplasia, type II | |
FKBP10 | Osteogenesis imperfecta, type XI (OI11) |
FKBP14 | Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss (EDSKMH) |
FLI1 | Ewing sarcoma (ES) |
Hemangiomatosis | |
Leukemia, acute lymphoblastic | |
Paris-Trousseau thrombocytopenia (TCPT) | |
FLNB | Atelosteogenesis, type I (AOI) (Spondylohumerofemoral hypoplasia) |
Atelosteogenesis, type III (AOIII) (AO3) | |
Boomerang dysplasia | |
Larsen syndrome (LRS), autosomal dominant | |
Spondylocarpotarsal synostosis syndrome (SCT) | |
FOXC2+del | Lymphedema, hereditary, type 2 (LMPH2) (Meige disease) |
Lymphedema-distichiasis syndrome (LYDS) | |
Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus | |
Yellow nail syndrome (YNS) (Lymphedema and yellow nails (LYYN)) | |
FOXG1+del | Rett syndrome, congenital variant (RTTCV) |
FOXI1 | Enlarged vestibular aqueduct (EVA) |
Pendred syndrome (PDS) | |
FOXL2+del+dup | Blepharophimosis, epicanthus inversus, and ptosis, type 1 (BPES1) |
Blepharophimosis, epicanthus inversus, and ptosis, type 2 (BPES2) | |
Premature ovarian failure 3 |
Gen | Krankheit |
IDH1 | Glioma (GLM) |
Leukemia, acute myeloid (AML) | |
Maffucci syndrome (Enchondromatosis, multiple, Maffucci type) | |
Metaphyseal chondromatosis with urinary excretion of D-2-hydroxy-glutaric acid (MC-HGA) | |
Ollier disease (Enchondromatosis, multiple, Ollier type) | |
Osteoarthritis, familial early-onset (FOA), susceptibility to | |
IDH2 | D-2-hydroxyglutaric aciduria type 2 (D2HGA2) |
Maffucci syndrome (= Enchondromatosis, multiple, Maffucci type) | |
Metaphyseal chondromatosis with urinary excretion of D-2-hydroxy-glutaric acid (MC-HGA) | |
Ollier disease (Enchondromatosis, multiple, Ollier type) | |
IFITM5 | Osteogenesis imperfecta, type 5 (OI5) |
IFT20 | ciliary assembly, function in |
IFT25 (offiz. HSPB11) | apoptotic cell death, role in prevention of |
IFT27 | protein is ras-related, but the function is unknown |
IFT43 | Cranioectodermal dysplasia 3 (CED3) |
IFT80 | Asphyxiating thoracic dystrophy 2 (ATD2) (Jeune syndrome 2) |
IFT122 | Cranioectodermal dysplasia type 1 (CED1) |
IGFALS | Acid-labile subunit, deficiency of (ALSD) |
IHH | Acrocapitofemoral dysplasia (ACFD) |
Brachydactyly, type A1 (BDA1) | |
IKBKG (=NEMO)+del | Atypical mycobacteriosis, familial (AMCBX1) |
Ectodermal dysplasia, anhidrotic, with immune deficiency (EDA-ID) | |
Ectodermal dysplasia, hypohidrotic, with immune deficiency (HED-ID) | |
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency | |
Immunodeficiency, isolated | |
Incontinentia pigmenti, type II, formerly | |
Invasive pneumococcal disease, recurrent isolated, 2 (IPD2) | |
IMPAD1 | chondrodysplasia with joint dislocations, GPAPP type (CDP-GPAPP) |
INI1 (offiz. SMARCB1)+del | Rhabdoid predisposition syndrome 1 (RPS1) |
Rhabdoid tumor (RDT) (Teratoid tumor, atypical) | |
Schwannomatosis (Neurofibromatosis type 3 (NF3)) | |
IRF6+del | Orofacial cleft 6, susceptibility to (OFC6) |
Popliteal pterygium syndrome 1 (PPS) | |
van der Woude syndrome 1 (VWS1) (Cleft lip and/or palate with mucous cysts of lower lip) | |
IVD | Isovaleric acidemia (IVA) |
JAG1+del+dup | Alagille syndrome, type 1 (ALGS1) |
Deafness, congenital heart defects, and posterior embryotoxon | |
Tetralogy of Fallot (TOF) | |
JAK2 | Budd-Chiari syndrome, susceptibility to (BDCHS) |
Erythrocytosis, somatic | |
Leukemia, acute myelogenous (AML) (= Leukemia, acute myeloid) | |
Myelofibrosis, somatic | |
Polycythemia vera (PV) (= Polycythemia rubra vera (PRV)) | |
Thrombocythemia 3 (THCYT3) (= Thrombocytosis) | |
KAL1+del | Kallmann syndrome 1 (KAL1) (Hypogonadotropic hypogonadism and anosmia (HHA)) |
KAL2+del (offiz. FGFR1) | Hypogonadotropic hypogonadism |
Jackson-Weiss syndrome (JWS) (craniosynostosis, midfacial hypoplasia, and foot anomalies) | |
Kallmann syndrome 2 (KAL2) | |
Osteoglophonic dysplasia (OGD) | |
Pfeiffer syndrome (PS) (Acrocephalodyndactyly, type V ( ACS5)) | |
Trigonocephaly, nonsyndromic (TRICEPH) (Craniosynostosis, metopic) | |
KAL3 (offiz. PROKR2) | Kallmann syndrome 3 |
KAL4 (offiz. PROK2) | Hypogonadism, hypogonadotropic |
Kallmann syndrome 4 | |
KAL5 (off. CHD7)+del | CHARGE syndrome |
hypogonadotropic hypogonadism, idiopathic (IHH) | |
idiopathic scoliosis 3, susceptibility to (IS3) | |
Kallmann syndrome 5 (KAL5) | |
KCNJ11 | Diabetes mellitus, permanent neonatal (PNDM) (Diabetes mellitus, permanent, of infancy (PDMI) |
Diabetes mellitus, permanent neonatal, with neurologic features | |
Diabetes mellitus, transient neonatal, 3 (TNDM3) | |
Diabetes mellitus, type 2, susceptibility to (= noninsulin-dependent diabetes mellitus (NIDDM), susceptibility to) | |
Hyperinsulinemic hypoglycemia, familial, 2 (HHF2) | |
KCTD1 | Scalp-ear-nipple syndrome (SENS) (Finlay-Marks syndrome) |
KIF7 | Acrocallosal syndrome |
Hydrolethalus syndrome 2 | |
Joubert syndrome 12 | |
KIF22 | Spondyloepimetaphyseal dysplasia with joint laxity, type 2 (SEMDJL2) |
KISS1R | Hypogonadotropic hypogonadism |
Precocious puberty, central | |
KIT+del | Gastrointestinal stromal tumor, familial (GIST) |
Leukemia, acute myeloid (AML) | |
Mast cell disease (= Mastocytosis) | |
Testicular germ cell tumors (TGCT) (Male germ cell tumor (MGCT)) | |
Piebald trait (PBT) (Piebaldism) | |
Urticaria pigmentosa | |
KRAS | Bladder cancer, somatic |
Breast cancer, somatic | |
Cardiofaciocutaneous syndrome 2 (CFC2) | |
Gastric cancer, somatic | |
Leukemia, acute myeloid (AML) | |
Lung cancer, somatic | |
Noonan syndrome 3 (NS3) | |
Pancreatic cancer, somatic | |
Schimmelpfennig-Feuerstein-Mims syndrome (SFM), somatic mosaic | |
KRT14 | Dermatopathia pigmentosa reticularis (DPR) |
Epidermolysis bullosa simplex Dowling-Meara type (EBS-DM) | |
Epidermolysis bullosa simplex Koebner type (EBS-K) | |
Epidermolysis bullosa simplex Weber-Cockayne type (EBS-WC) | |
Epidermolysis bullosa simplex, autosomal recessive (AREBS) | |
Naegeli-Franceschetti-Jadassohn syndrome (NFJS) (Naegeli syndrome) |
Gen | Krankheit |
L2HGDH+del | L-2-Hydroxyglutaric aciduria |
LAD (offiz. DLD) | Dihydrolipoamide dehydrogenase deficiency (DLDD) (E3 deficiency) (Maple syrup urine disease, type III) |
LAMP2+del | Danon disease (DAND) (= Glycogen storage disease type 2B (GSD2B), formerly) |
LAMR1 (offiz. RPSA) | Asplenia, isolated congenital |
LEPRE1+del | Osteogenesis imperfecta, type 8 (OI8) |
LFNG | Spondylocostal dysostosis, type 3 (SCDO3) |
LHX3+del | Pituitary hormone deficiency, combined, 3 (CPHD3) |
LHX4+del | Leukemia, acute lymphoblastic (ALL) |
Pituitary hormone deficiency, combined, 4 (CPHD4) | |
LIFR | Adenomas, salivary gland pleomorphic (PSA; SGPA) |
Stueve-Wiedemann syndrome (SWS) (Schwartz-Jampel syndrome, type 2 (SJS2)) | |
LMNA+del | Cardiomyopathy, dilated, 1A (CMD1A) |
Charcot-Marie-Tooth disease, axonal, type 2B1 (CMT2B1) | |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) | |
Emery-Dreifuss muscular dystrophy, atypical, autosomal recessive | |
Heart-hand syndrome, Slovenian type | |
Hutchinson-Gilford progeria syndrome (HGPS) (= Progeria) | |
Lipodystrophy, familial partial, type 2 (FPLD2) (Dunnigan type) | |
Malouf syndrome (Cardiomyopathy, dilated, with hypergonadotropic hypogonadism) | |
Mandibuloacral dysplasia with type A lipodystrophy (MADA) (Craniomandibular dermatodysostosis) | |
Mandibuloacral dysplasia with type A lipodystrophy, atypical | |
Muscular dystrophy, congenital, LMNA-related (MDCL) | |
Muscular dystrophy, limb-girdle, type 1B (LGMD1B) | |
Progeria syndrome, childhood onset | |
Restrictive dermopathy, lethal (Tight skin contracture syndrome, lethal) | |
LMNB2 | Lipodystrophy, partial, acquired, susceptibility to (APLD) (Barraquer-Simons syndrome) |
LMX1B+del | Nail-patella syndrome (NPS) (Onychoosteodysplasia) |
Nail-patella syndrome with primary open angle glaucoma (POAG) | |
LNP (offiz. NUSAP1) | spindle microtubule organization, role in |
LPIN2 | Majeed syndrome (MAJEEDS) (chronic recurrent multifocal osteomyelitis (CRMO), congenital dyserythropoietic anemia (CDA), and neutrophilic dermatosis (Sweet syndrome)) |
LPL+del+dup | Hyperlipidemia, familial combined (FCHL) |
Hyperlipoproteinemia, type I (Lipoprotein lipase (LPL) deficiency) | |
MAFB | Multicentric carpotarsal osteolysis syndrome (MCTO) |
MAP2K1 (=MEK1) | Cardiofaciocutaneous syndrome 3 (CFC3) |
MAP2K2 (=MEK2) | Cardiofaciocutaneous syndrome 4 (CFC4) |
MAT1A | Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency |
Methionine adenosyltransferase (MAT) deficiency, autosomal recessive | |
MATN3 | Epiphyseal dysplasia, multiple, 5 (EDM5) |
Osteoarthritis, susceptibility to, 2 (OS2) | |
Spondyloepimetaphyseal dysplasia (SEMD) | |
MBOAT1+del | Brachydactyly-syndactyly syndrome, novel |
MC4R | Obesity, autosomal dominant (OBESITY) |
MCAD (offiz. ACADM)+del | Acyl-CoA dehydrogenase medium chain (ACADM) deficiency = medium chain Acyl-CoA dehydrogenase deficiency (MCAD) |
MECP2+del+dup | Angelman syndrome-like |
Autism susceptibility, X-linked 3 (AUTSX3) | |
Encephalopathy, neonatal severe | |
Mental retardation, X-linked syndromic, Lubs type (MRXSL) (MECP2 duplication syndrome) | |
Mental retardation, X-linked, syndromic 13 (MRXS13) | |
Rett syndrome (RTT; RTS) | |
Rett syndrome, preserved speech variant (RTT-PSV) (Rett syndome, atypical) | |
MED12 | Lujan-Fryns syndrome (Mental retardation, X-linked, with marfanoid habitus) |
Ohdo syndrome, X-linked (OHDOX) (Blepharophimosis-mental retardation syndrome, Maat-Kievit-Brunner type) | |
Opitz-Kaveggia syndrome (OKS) (FG syndrome 1 (FGS1)) | |
MEF2C+del | Bone development and chondrocyte hypertrophy, control of |
Chondrocyte hypertrophy and bone development, control of | |
Mental retardation, autosomal dominant 20 (MRD20) | |
Chromosome 5q14.3 deletion syndrome | |
MEK1 (offiz. MAP2K1) | Cardiofaciocutaneous syndrome 3 (CFC3) |
MEK2 (offiz. MAP2K2) | Cardiofaciocutaneous syndrome 4 (CFC4) |
MESP2 | Spondylocostal dysostosis type 2 (SCDO2) |
MID1+del+dup | Opitz GBBB syndrome, X-linked (Opitz syndrome (OS)) |
MLH1+del | Cafe-au-lait spots with glioma or leukemia |
Colorectal cancer, hereditary nonpolyposis, type 2 (HNPCC2) | |
Endometrial cancer (ENDMC), susceptibility to | |
Lobular carcinoma in situ (LCIS) | |
Mismatch repair cancer syndrome (MMRCS) (Turcot syndrome) (Brain tumor-polyposis syndrome 1) | |
Muir-Torre syndrome (MRTES) | |
MLH3 | Colon cancer, hereditary nonpolyposis, type 7 (HNPCC7) |
Colorectal cancer, somatic (CRC) | |
Endometrial cancer | |
MLP (=C-MLP) | Myelofibrosis with myeloid metaplasia, somatic (MMM) |
Thrombocythemia 2 (THCYT2) | |
Thrombocytopenia, congenital amegakaryocytic (CAMT) | |
MMACHC | Methylmalonic aciduria and homocystinuria, cblC type |
MMP2 | Multicentric osteolysis, nodulosis, and arthropathy (MONA) (Nodulosis-arthropathy-osteolysis syndrome) |
MMP9 | Lumbar disc herniation (LDH), susceptibility to |
Metaphyseal anadysplasia type 2 (MANDP2) | |
MMP13 | Metaphyseal anadysplasia type 1 (MANDP1) |
Spondyloepimetaphyseal dysplasia, Missouri type (SEMD-MO) | |
MMP14 | Torg-Winchester syndrome (Nodulosis-arthropathy-osteolysis (NAO) syndrome) |
Winchester syndrome (WNCHRS) | |
MOPD2 (offiz. PCNT)+del | Microcephalic osteodysplastic primordial dwarfism, type II (MOPD2) (Osteodysplastic primordial dwarfism, type II) |
Seckel syndrome | |
MSH2+del | Cafe-au-lait spots, multiple, with leukemia (DD zu MMRCS) |
Colorectal cancer, hereditary nonpolyposis, type 1 (HNPCC1) (Lynch syndome 1) | |
Colorectal cancer, hereditary nonpolyposis, type 8 (HNPCC8) | |
Endometrial cancer (ENDMC), susceptibility to | |
Mismatch repair cancer syndrome (MMRCS) (Turcot syndrome (Brain tumor-polyposis syndrome 1) | |
Muir-Torre syndrome (MRTES) | |
Neurofibromatosis, type I, with leukemia (DD zu MMRCS) | |
MSH6+del | Colorectal cancer, hereditary nonpolyposis, type 5 (HNPCC5) |
Endometrial cancer, familial (ENDMC) | |
Mismatch repair cancer syndrome (MMRCS) (Turcot syndrome (Brain tumor-polyposis syndrome 1) | |
Ovarian cancer, endometrioid type | |
MSX2+del | Craniosynostosis, type 2 (CRS2) (Craniosynostosis Boston-type (CSB)) |
Parietal foramina 1 (PFM1) (Cranium bifidum occultum) | |
Parietal foramina with cleidocranial dysplasia (PFMCCD) (Cleidocranial dysplasia with parietal foramina) | |
MYH3 | Arthrogryposis, distal, type 2A (DA2A) (Freeman-Sheldon syndrome (FSS)) |
Arthrogryposis, distal, type 2B (DA2B) (Sheldon-Hall syndrome (SHS)) )Arthrogryposis multiplex congenita, distal, type 2B (AMCD2B)) | |
MYH11+dup | Aortic aneurysm, familial thoracic 4 (AAT4) |
MYLK | Aortic aneurysm, familial thoracic 7 (AAT7) |
MYO6 | Deafness, autosomal dominant 22 (DFNA22) |
Deafness, autosomal dominant 22 (DFNA22), with hypertrophic cardiomyopathy | |
Deafness, autosomal recessive 37 (DFNB37) |
Gen | Krankheit |
NALP3 (offiz. NLRP3) | CINCA (chronic infantile neurologic cutaneous and articular) syndrome |
Cold-induced autoinflammatory syndrome, familial (FCAS) (Cold urticaria, familial (FCU)) | |
Muckle-Wells syndrome (MWS) (Urticaria-deafness-amyloidosis (UDA) syndrome) | |
NALP12 (offiz. NLRP12) | Cold autoinflammatory syndrome type 2, familial (FCAS2) |
NELF | Hypogonadotropic hypogonadism |
Kallmann syndrome | |
NEMO (offiz. IKBKG)+del | Atypical mycobacteriosis, familial (AMCBX1) |
Ectodermal dysplasia, anhidrotic, with immune deficiency (EDA-ID) | |
Ectodermal dysplasia, hypohidrotic, with immune deficiency (HED-ID) | |
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency | |
Immunodeficiency, isolated | |
Incontinentia pigmenti, type II, formerly (IP2, formerly) | |
Invasive pneumococcal disease, recurrent isolated, 2 (IPD2) | |
NF1+del | Leukemia, juvenile myelomonocytic (JMML) |
Melanoma, desmoplastic neurotrophic (DNM) | |
Neurofibromatosis, familial spinal (FSNF) | |
Neurofibromatosis, type 1 ( Von recklinghausen disease) | |
Neurofibromatosis-Noonan syndrome (NFNS) | |
Watson syndrome (= Pulmonic stenosis with cafe-au-lait spots) | |
NFIX | Marshall-Smith syndrome (MSS) |
Sotos syndrome 2 | |
NHP2 (=NOLA2) | Dyskeratosis congenita, autosomal recessive 2 (DKCB2) |
NIPBL+del | Cornelia de Lange syndrome type 1 (CDLS1) |
NKX2-5 | Atrial septal defect 7, with or without AV conduction defects (ASD7) |
Conotruncal heart malformations, variable (CTHM) | |
Hypoplastic left heart syndrome 2 (HLHS2) | |
Hypothyroidism, congenital nongoitrous, 5 (CHNG5) | |
Tetrology of Fallot (TOF) | |
Truncus arteriosus communis (Persistent truncus arteriosus (PTA)) | |
Ventricular septal defect 3 (VSD3) | |
NLRP3 (=NALP3) | CINCA (chronic infantile neurologic cutaneous and articular) syndrome (CINCA) |
Cold-induced autoinflammatory syndrome, familial (FCAS) (Cold urticaria, familial (FCU)) | |
Muckle-Wells syndrome (MWS) (Urticaria-deafness-amyloidosis (UDA) syndrome) | |
NLRP12 (=NALP12) | Cold autoinflammatory syndrome type 2, familial (FCAS2) |
NOG | Brachydactyly, type B2 (BDB2) |
Multiple synostosis syndrome 1 (SYNS1) (Symphalangism-brachydactyly syndrome) | |
Stapes ankylosis with broad thumb and toes (SABTS) (Teunissen-Cremers syndrome) | |
Symphalangism, proximal (SYM1) (Cushing symphalangism) | |
Synostosis of talus and calcaneus with short stature | |
Tarsal-carpal coalition syndrome (TCC) | |
NOLA2 (offiz. NHP2) | Dyskeratosis congenita, autosomal recessive 2 (DKCB2) |
NOLA3 (offiz. NOP10) | Dyskeratosis congenita, autosomal recessive 1 (DKCB1) |
NOP10 (=NOLA3) | Dyskeratosis congenita, autosomal recessive 1 (DKCB1) |
NOTCH1+del | Aortic valve disease 1 (AOVD1) |
Leukemia, T-cell acute lymphoblastic | |
NPR2 | Acromesomelic dysplasia, Maroteaux type (AMDM) |
St. Helena dysplasia | |
NPR3 | Hypertension, salt-resistant (?) |
NR5A1 | 46,XY sex reversal 3 (SRXY3) |
Adrenocortical insufficiency | |
Hypogonadotropic hypogonadism with or without anosmia (HH) | |
Premature ovarian failure 7 (POF7) | |
Spermatogenic failure 8 (SPGF8) | |
NRXN1+del | Pitt-Hopkins-like syndrome 2 (PTHSL2) |
Chromosome 2p16.3 deletion syndrome | |
Schizophrenia, susceptibility to, 17 | |
NSD1 (=SOTOS)+del | Beckwith-Wiedemann syndrome (BWS) |
Leukemia, acute myeloid (AML) | |
Sotos syndrome (SOTOSS) (Cerebral gigantism) | |
NUSAP1 (=LNP) | spindle microtubule organization, role in |
OBSL1 | 3M syndrome 2 (3M2) |
OPG (offiz. TNFRSF11B) | Paget disease, juvenile (JPD) (Hyperphosphatasia, hereditary) |
OTX2+del | Microphthalmia, syndromic 5 (MCOPS5) |
Pituitary hormone deficiency, combined, 6 (CPHD6) | |
Retinal dystrophy, early-onset, and pituitary dysfunction |
Gen | Krankheit |
p63 (offiz. TP63) | ADULT (Acro-dermato-ungual-lacrimal-tooth) syndrome |
Cervical cancer | |
Colon cancer | |
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) | |
Hay-Wells syndrome (ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome) | |
Head cancer | |
Limb-mammary syndrome (LMS) | |
Lung cancer | |
Neck cancer | |
Orofacial cleft 8 (OFC8) | |
Ovarian cancer | |
Rapp-Hodgkin syndrome (RHS) (= Ectodermal dysplasia Rapp-Hodgkin type (EDRH)) | |
Split-hand/foot malformation 4 (SHFM4) | |
PACSIN3 | vesicle formation and transport, role in |
PAH+del | Hyperphenylalaninemia, mild (HPA, mild) |
Hyperphenylalaninemia, non-PKU mild (HPA, non-PKU mild) | |
Phenylketonuria (PKU) (PAH deficiency) | |
PAPSS2 | Brachyolmia, autosomal recessive |
Spondylodysplasia and premature pubarche | |
Spondyloepimetaphyseal dysplasia, Pakistani type (SEMD, PA) | |
PAX2+del | Optic nerve coloboma with renal disease (Renal-coloboma syndrome) |
Renal hypoplasia, isolated | |
PAX3+del | Craniofacial-deafness-hand syndrome (CDHS) |
Rhabdomyosarcoma 2 (RMS2) (Rhabdomyosarcoma, alveolar (RMSA)) | |
Waardenburg syndrome, type 1 (WS1) | |
Waardenburg syndrome, type 3 (WS3) | |
PAX6+del | Aniridia (AN) (Aniridia II (AN2), formerly) |
Cataract with late-onset corneal dystrophy | |
Coloboma of optic nerve (COLON) | |
Coloboma, ocular (COLO) | |
Ectopia pupillae | |
Foveal hypoplasia and presenile cataract syndrome (O'Donnell-Papas syndrome) | |
Foveal hypoplasia with anterior segment anomalies | |
Foveal hypoplasia, isolated | |
Gillespie syndrome (GS) (Aniridia, cerebellar ataxia, and mental deficiency (ACAMD)) | |
Keratitis, hereditary (KERH) | |
Morning glory disc anomaly | |
Optic nerve aplasia, bilateral (BONA) | |
Optic nerve head pits, bilateral, congenital | |
Optic nerve hypoplasia, bilateral (BONH) | |
Peters anomaly (PAN) | |
WAGR (Wilms tumor, aniridia, genitourinary anomalies , and mental retardation) syndrome (chromosome 11p13 deletion syndrome) | |
WAGRO (Wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity) syndrome (chromosome 11p13-p12 deletion syndrome) | |
PC | Pyruvate carboxylase (PC) deficiency |
PCNT (=MOPD2)+del | Microcephalic osteodysplastic primordial dwarfism, type II (MOPD2) |
Seckel syndrome | |
PDE4D | Acrodysostosis type 2, with or without hormone resistance (ACRDYS2) |
PEX7+del | Refsum disease, adult (RDA) (Motor and sensory neuropathy, hereditary, 4 (HMSN4)) |
Rhizomelic chondrodysplasia punctata, type 1 (RCDP1) (Chondrodysplasia punctata, rhizomelic form) | |
PGN (offiz. SPG7)+del | Spastic paraplegia 7, autosomal recessive (SPG7) |
PHEX+del+dup | Hypophosphatemic rickets, X-linked dominant (XLHR) (Vitamin D-resistant rickets, X-linked) |
PIN1 | Hypogonadotropic Hypogonadism without anosmia |
PITX2+del | Axenfeld-Rieger syndrome, type 1 (RIEG1) (Rieger syndrome type 1) |
Iridogoniodysgenesis, type 2 (IRID2) | |
Peters anomaly (PAN) | |
Ring dermoid of cornea (RDC) | |
PLCG2 (nur del) | Familial cold autoinflammatory syndrome 3 (FCAS3) |
PLOD1+del+dup | Ehlers-Danlos syndrome, type VI (EDS6) (EDS, kyphoscoliotic type) |
PLOD2 | Bruck syndrome 2 (BRKS2) (Osteogenesis imperfecta with congenital joint contractures) |
PMS2+del | Colorectal cancer, hereditary nonpolyposis, type 4 (HNPCC4) (Lynch syndrome 4) |
Mismatch repair cancer syndrome (MMRCS) (Turcot syndrome) (Brain tumor-polyposis syndrome 1) | |
POMC | Obesity, early-onset, susceptibility to |
Proopiomelanocortin deficiency (Obesity, adrenal insufficiency, and red hair) | |
POP1 | Anauxetic dysplasia (Spondylometaepiphyseal dysplasia, Menger type) |
POR+del | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis (ABS1) |
Cytochrome P450 oxidoreductase deficiency (POR deficiency) | |
Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) | |
PORCN+del | Focal dermal hypoplasia (FODH) (Goltz syndrome; Goltz-Gorlin syndrome) |
POU1F1+del | Pituitary hormone deficiency, combined, 1 (CPHD1) |
PPIB | Osteogenesis imperfecta, type IX (OI9) |
PRKAR1A+del | Acrodysostosis 1, with or without hormone resistance (ACRDYS1) |
Adrenocortical tumor, somatic | |
Carney complex, type 1 (CNC1) | |
Myxoma, intracardiac (INTMYX) | |
Pigmented nodular adrenocortical disease, primary, 1 (PPNAD1) (Cushing syndrome, adrenal, due to PPNAD1) | |
Thyroid carcinoma, papillary, somatic (PTC) | |
PRKG1 (=CGKI) | nitric oxide/cGMP signaling pathway, key mediators |
signal transduction processes in diverse cell types, important components | |
PROK2 (=KAL4) | Hypogonadism, hypogonadotropic |
Kallmann syndrome 4 | |
PROKR2 (=KAL3) | Kallmann syndrome 3 |
PROP1+del | Pituitary hormone deficiency, combined, 2 (CPHD2) (Panhypopituitarism) |
PRSS1 | Pancreatitis, hereditary (PCTT) |
Trypsinogen deficiency | |
PTCH1+del | Basal cell carcinoma, somatic (BCC) |
Basal cell nevus syndrome (BCNS) (Gorlin syndrome; Gorlin-Goltz syndrome) | |
Holoprosencephaly-7 (HPE7) | |
Medulloblastoma, somatic (MDB) | |
PTCH2 | Basal cell carcinoma, somatic (BCC) |
Macrostomia, isolated (Lateral cleft, isolated) | |
Medulloblastoma, somatic (MDB) | |
PTEN+del | Bannayan-Riley-Ruvalcaba syndrome (BRRS) |
Chromosome 10q23 deletion syndrome | |
Cowden disease (CD) (Cowden syndrome (CS)) (Multiple hamartoma syndrome (MHAM)) | |
Endometrial carcinoma, somatic (ENDMC) | |
Glioma susceptibility 2 (GLM2) | |
Juvenile polyposis syndrome, infantile | |
Lhermitte-Duclos syndrome (LDD) (Cerebelloparenchymal disorder VI (CPD6)) | |
Macrocephaly/autism syndrome (MCEPHAS) | |
Melanoma, malignant, somatic | |
Meningioma | |
Meningioma | |
Oligodendroglioma | |
Prostate cancer, somatic (PC) | |
Proteus syndrome | |
PTEN hamartoma tumor syndrome (PHTS) (includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), Proteus syndrome (PS), and Proteus-like syndrome) | |
Squamous cell carcinoma, head and neck, somatic (HNSCC) | |
Thyroid carcinoma, follicular, somatic (FTC) | |
VATERL (vertebral anomalies, anal atresia, congenital cardiac disease, tracheoesophageal fistula, renal anomalies, radial dysplasia, and other limb defects) with macrocephaly and ventriculomegaly association | |
PTH1R (= PTHR) | Chondrodysplasia, Blomstrand type (BOCD) |
Eiken syndrome (Bone modeling defect of hands and feet) | |
Enchondromatosis, multiple, Ollier type (ENCHOM) (Osteochondromatosis) | |
Failure of tooth eruption, primary (PFE) | |
Metaphyseal chondrodysplasia, Murk Jansen type | |
PTPN1 | Insulin resistance, susceptibility to |
PTPN11+del+dup | Leukemia, juvenile myelomonocytic (JMML) |
Pterygium colli syndrome | |
LEOPARD (multiple lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormal genitalia, retardation of growth, and sensorineural deafness) syndrome 1 | |
Metachondromatosis (METCDS) | |
Noonan syndrome 1 (NS1) | |
PTRF | Lipodystrophy, congenital generalized, type 4 (CGL4) (Berardinelli-Seip congenital lipodystrophy, type 4, with muscular dystrophy) |
PYCR1+del | Cutis laxa autosomal recessive type 2B (ARCL2B) (Cutis laxa with progeroid features) |
Cutis laxa autosomal recessive type IIIB (ARCL3B) (De Barsy Syndrome B) |
Gen | Krankheit |
RAB23 | Carpenter syndrome (CARPS) (Acrocephalopolysyndactyly type 2 (ACPS2)) |
RAF1+del+dup | LEOPARD syndrome 2 |
Noonan syndrome 5 (NS5) | |
RAG1+del | Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity (T-CMVA) |
Combined cellular and humoral immune defects with granulomas (CCHIDG) | |
Omenn syndrome (OS) (Severe combined immunodeficiency with hypereosinophilia) | |
Severe combined immunodeficiency, B cell-negative (B- SCID) | |
RAG2+del | Combined cellular and humoral immune defects with granulomas (CCHIDG) |
Omenn syndrome (OS) (Severe combined immunodeficiency with hypereosinophilia) | |
Severe combined immunodeficiency, B cell-negative (= B- SCID) | |
RIT1 | Noonan syndrome 8 (NS8) |
RMRP | Anauxetic dysplasia (Spondylometaepiphyseal dysplasia, Menger type) |
Cartilage-hair hypoplasia (CHH) (Metaphyseal chondrodysplasia, McKusick type) | |
Metaphyseal dysplasia without hypotrichosis (Cartilage-hair hypoplasia-like skeletal dysplasia without hypotrichosis or immunodeficiency) | |
RNU4ATAC | Microcephalic osteodysplastic primordial dwarfism, type I (MOPD1) (Taybi-Linder syndrome (TALS)) |
RPL5 | Aase syndrome |
Aase-Smith syndrome II | |
Diamond-Blackfan anemia 6 | |
RPL11 | Diamond-Blackfan anemia 7 |
RPL15 | Diamond-Blackfan anemia 12 |
RPL26 | Diamond-Blackfan anemia 11 |
RPL35A | Diamond-Blackfan anemia 5 |
RPS6KA3 (=RSK2) +del+dup | Coffin-Lowry syndrome (CLS) |
Mental retardation, X-linked 19 (MRX19) | |
RPS7 | Diamond-Blackfan anemia 8 |
RPS10 | Diamond-Blackfan anemia 9 |
RPS15 | Diamond-Blackfan anemia, candidate |
RPS17 | Diamond-Blackfan anemia 4 |
RPS19 | Aase syndrome |
Aase-Smith syndrome II | |
Anemia, congenital erythroid hypoplastic | |
Anemia, congenital hypoplastic, of Blackfan and Diamond | |
Aregenerative anemia, chronic congenital | |
Blackfan-Diamond Syndrome; BDS | |
Diamond-Blackfan anemia 1 (DBA1) (DBA) | |
Erythrogenesis imperfecta | |
Red cell aplasia, pure, hereditary | |
RPS24 | Diamond-blackfan anemia 3 |
RPS26 | Diamond-Blackfan anemia 10 |
RPSA (= LAMR1) | Asplenia, isolated congenital |
RSK2 (offiz. RPS6KA3) +del+dup | Coffin-Lowry syndrome (CLS) |
Mental retardation, X-linked 19 (MRX19) | |
RTEL1 | Dyskeratosis congenita, autosomal dominant 4 (DKCA4) |
RTEL1 | Dyskeratosis congenita, autosomal recessive 5 (DKCB5) |
RUNX1 | Leukemia, acute myeloid |
RUNX1 | Platelet disorder, familial, with associated myeloid malignancy (FPDMM) |
RUNX2+del | Cleidocranial dysplasia (CCD) (= Cleidocranial dysostosis (CLCD)) |
Dental anomalies, isolated | |
SALL1+del | Townes-Brocks branchiootorenal-like syndrome |
Townes-Brocks syndrome (TBS) (Renal-ear-anal-radial syndrome) | |
SBDS+del | Shwachman-Bodian-Diamond syndrome (SBDS) (Pancreatic insufficiency and bone marrow dysfunction) |
SCYL1BP1 (offiz. GORAB) | Geroderma osteodysplasticum (GO) (Walt Disney dwarfism) |
SDCBP | Role in linking syndecan-mediated signaling to the cytoskeleton, cytoskeletal-membrane organization, cell adhesion, protein trafficking, and the activation of transcription factors; perhaps a role in melanoma differentiation and neurofibromatosis II |
SECISBP2+del | Thyroid hormone metabolism, abnormal |
SEDLIN (offiz. TRAPPC2)+del | Spondyloepiphyseal dysplasia tarda, X-linked (SEDT) |
SEMA3A+del | Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) |
SERPINF1 | Osteogenesis imperfecta, type VI (OI6) |
SERPING1 (=C1NH)+del | Angioedema, hereditary, type I (HAE1) (C1 esterase inhibitor, deficiency of) |
Angioedema, hereditary, type II (HAE2) | |
Complement component 4 (C4), partial deficiency of | |
SERPINH1 | Osteogenesis imperfecta, type X (OI10) |
Preterm premature rupture of the membranes, susceptibility to (PPROM) | |
SETBP1 | Leukemia, acute T-cell lymphoblastic |
Schinzel-Giedion midface retraction syndrome (SGS) | |
SHOX+del | Langer mesomelic dysplasia (LMD) (Dyschondosteosis, homozygous) |
Leri-Weill dyschondrosteosis (LWD) (Dyschondrosteosis (DCO)) | |
Short stature, idiopathic, X-linked (ISS) | |
SIX6 | Microphthalmia, isolated, with cataract 2 (MCOPCT2) |
SKI | Shprintzen-Goldberg craniosynostosis syndrome (SGS) (Craniosynostosis with arachnodyctyly and abdominal hernias) |
SLC5A2+del | Renal glucosuria (GLYS1) |
SLC6A8+del | Cerebral creatine deficiency syndrome 1 (CCDS1) |
SLC16A2 (=MCT8)+del | Allan-Herndon-Dudley syndrome (AHDS) (Monocarboxylate transporter 8 (MCT8) deficiency) (T3 resistance) (Mental retardation, X-linked, with hypotonia) |
SLC26A2 (=DTDST) | Achondrogenesis Ib (ACG1B) |
Atelosteogenesis II (AO2) | |
De la Chapelle dysplasia (DLCD) | |
Diastrophic dysplasia (DTD) | |
Diastrophic dysplasia, broad bone-platyspondylic variant (DTDB) | |
Epiphyseal dysplasia, multiple, 4 (EDM4) | |
SLC34A1 | Fanconi renotubular syndrome 2 (FRTS2) |
Nephrolithiasis/osteoporosis, hypophosphatemic, 1 (NPHLOP1) | |
SLC34A3+del | Hypophosphatemic rickets with hypercalciuria (HHRH) |
SLC46A1 | Folate malabsorption, hereditary (HFM) |
SMAD3 | Loeys-Dietz syndrome, type 3 (LDS3) (Aneurysms-osteoarthritis syndrome) |
SMAD4 | Colorectal cancer (CRC) |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JPHT) | |
Myhre syndrome (MYHRS) (Growth-mental deficiency syndrome of Myhre) | |
Pancreatic cancer (PNCA) | |
Polyposis, juvenile intestinal (PJI) | |
SMARCA4 | Rhabdoid tumor predisposition syndrome 2 (RTPS2) |
SMARCB1 (=INI1)+del | Rhabdoid predisposition syndrome 1 (RPS1) |
Rhabdoid tumor (RDT) (Teratoid tumor, atypical) | |
Schwannomatosis (Neurofibromatosis type 3 (NF3)) | |
SMC1A (=SMC1L1)+del+dup | Cornelia de Lange syndrome type 2 (CDLS2) |
SMC3 | Cornelia de Lange syndrome type 3 (CDLS3) |
SNAI2+del | Piebald trait (PBT) (= Piebaldism) |
Waardenburg syndrome, type 2D (WS2D) | |
SOS1 | Fibromatosis, gingival, 1 (GINGF1) |
Noonan syndrome 4 (NS4) | |
SOST | Craniodiaphyseal dysplasia, autosomal dominant (CDD) |
Sclerosteosis 1 (SOST1) (Hyperostosis, cortical, with syndactyly) | |
Van Buchem disease (VBCH) (Hyperostosis corticalis generalis) | |
SOTOS (offiz. NSD1)+del | Beckwith-Wiedemann syndrome (BWS) |
Leukemia, acute myeloid (AML) | |
Sotos syndrome (SOTOSS) | |
Weaver syndrome (WES) | |
SOX2+del | Microphthalmia, syndromic 3 (MCOPS3) |
Optic nerve hypoplasia and abnormalities of the central nervous system | |
SP7 | Osteogenesis imperfecta, type XII (OI12) |
SPAST | Spastic paraplegia 4, autosomal dominant |
SPG7 (=PGN)+del | Spastic paraplegia 7, autosomal recessive (SPG7) |
SPINK5 | Atopy |
Netherton syndrome (NETH) (= NS = Netherton disease) | |
SRCAP | Floating-Harbor syndrome (FLHS) |
SRP72 | Bone marrow failure, familial (BMFF) |
SRY | 46,XX sex reversal 1 (SRXX1) (46,XX Gonadal dysgenesis, complete, SRY-positive) |
46,XY sex reversal 1 (SRXY1) (46,XY Gonadal dysgenesis, complete, SRY-related) | |
46,XY True hermaphroditism, SRY-related | |
46;XX True hermaphroditism, SRY-positive (Ovotesticular disorder of sex development) | |
Swyer syndrome (46, XY Gonadal dysgenesis, complete) | |
STK11 | Lung cancer, non-small cell (NSCLC) |
Melanoma, malignant sporadic | |
Pancreatic cancer, sporadic | |
Peutz-Jeghers syndrome (PJS) (Polyposis, hamartomatous intestinal) | |
Testicular tumor, sporadic | |
SUFU+del | Medulloblastoma, desmoplastic (MDB, desmoplastic) |
Gen | Krankheit |
TAC3 | Hypogonadotropic hypogonadism |
TACR3 | Hypogonadotropic hypogonadism |
TBX5+del+dup | Holt-Oram syndrome (HOS) (Heart-hand syndrome) (Atriodigital dysplasia) |
TBX6+dup | Spondylocostal dysostosis, autosomal dominant (SCDO) |
TBX15 | Cousin syndrome (COUSS) (Craniofacial dysmorphism, hypoplasia of scapula and pelvis, and short stature) (Pelviscapular dysplasia) |
TBX18 | anterior and posterior somite compartments, maintains the separation of |
otic fibrocyte differentiation, role in | |
posterior pole of the heart, role in formation of posterior pole of the | |
ureter, role in formation of | |
vertebral column, role in formation of | |
TCAB1 (offiz. WRAP53) | Dyskeratosis congenita, autosomal recessive 3 |
TCOF1+del | Hemifacial microsomia (HFM) (Goldenhar syndrome) (Oculoauriculovertebral dysplasia (OAVD)) |
Treacher Collins syndrome 1 (TCS1) | |
TCTN3 | Joubert syndrome 18 (JBTS18) |
Orofaciodigital syndrome IV (OFD4) (Mohr-Majewski syndrome) | |
TEM8 (offiz. ANTXR1) | Hemangioma, capillary infantile, susceptibility to |
TERC | Aplastic anemia, susceptibility to (AA) |
Dyskeratosis congenita, autosomal dominant 1 | |
Pulmonary fibrosis, idiopathic, susceptibility to (IPF) | |
TERT | Bone marrow failure, telomere-related, 1 |
Coronary artery disease | |
Dyskeratosis congenita, autosomal dominant 2 | |
Dyskeratosis congenita, autosomal recessive 4 | |
Leukemia, acute myeloid | |
Melanoma, cutaneous malignant, 9 | |
Pulmonary fibrosis, telomere-related, 1 | |
TGFB2+del | Loeys-Dietz syndrome, type 4 (LDS4) |
TGFBR1+dup | Loeys-Dietz syndrome, type 1A (LDS1A) (Furlong syndrome) |
Loeys-Dietz syndrome, type 2A (LDS2A) (Aortic aneurysm, familial thoracic 5 (AAT5)) | |
Multiple self-healing squamous epithelioma, susceptiblity to (MSSE) | |
TGFBR2 | Colorectal cancer, hereditary nonpolyposis, type 6 (HNPCC6) |
Esophageal cancer, somatic | |
Loeys-Dietz syndrome, type 1B (LDS1B) | |
Loeys-Dietz syndrome, type 2B (LDS2B) (Aortic aneurysm, familial thoracic 3 (AAT3)) | |
THRB | Thyroid hormone resistance, generalized, autosomal dominant (GRTH = GTHR) |
Thyroid hormone resistance, generalized, autosomal recessive (GRTH) (Refetoff syndrome) | |
Thyroid hormone resistance, selective pituitary (PRTH) | |
TINF2 | Dyskeratosis congenita, autosomal dominant, 3 (DKCA3) |
TINF2 | Revesz syndrome (exudative retinopathy with bone marrow failure (ERBMF)) |
TMEM38B+del | Osteogenesis imperfecta, autosomal recessive |
TNFRSF11B (=OPG) | Paget disease, juvenile (JPD) (Hyperphosphatasia, chronic congenital idiopathic) |
TNNI2 | Arthrogryposis multiplex congenita, distal, type 2B (AMCD2B) |
TNNI3 | Cardiomyopathy, dilated, 1FF |
Cardiomyopathy, dilated, 2A | |
Cardiomyopathy, familial hypertrophic, 7 | |
Cardiomyopathy, familial restrictive | |
TNNT3 | Arthyrgryposis, distal, type 2B (DA2B) (= Arthrogryposis multiplex congenita, distal, type 2B (AMCD2B)) (Sheldon-Hall syndrome (SHS)) |
TNSALP (offiz. ALPL)+del | Hypophosphatasia (HOPS), adult, childhood, infantile or perinatal lethal |
Odontohypophosphatasia | |
TP63 (=p63) | ADULT (Acro-dermato-ungual-lacrimal-tooth) syndrome |
Cervical cancer | |
Colon cancer | |
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) | |
Hay-Wells syndrome (ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome) | |
Head cancer | |
Limb-mammary syndrome (LMS) | |
Lung cancer | |
Neck cancer | |
Orofacial cleft 8 (OFC8) | |
Ovarian cancer | |
Rapp-Hodgkin syndrome (RHS) (Ectodermal dysplasia, anhidrotic, with cleft lip/palate) | |
Split-hand/foot malformation 4 (SHFM4) | |
TPM1 | Cardiomyopathy, dilated, 1Y (CMD1Y) |
Cardiomyopathy, familial hypertrophic, 3 (CMH3) | |
TPM2 | Arthrogryposis, distal, type 1A (DA1A) (Arthrogryposis multiplex congenita, distal, type 1 (AMCD1)) |
Arthrogryposis, distal, type 2B (DA2B) (Sheldon-Hall syndrome (SHS)) | |
Nemaline myopathy 4 (NEM4) | |
TRAPPC2 (= SEDLIN)+del | Spondyloepiphyseal dysplasia tarda, X-linked (SEDT) |
TRIP11 | Achondrogenesis, type IA (ACG1A) (Achondrogenesis, Houston-Harris type) |
Leukemia, acute myelogenous | |
TRPS1+del | Trichorhinophalangeal syndrome, type I (TRPS1) |
Trichorhinophalangeal syndrome, type III (TRPS3) (Sugio-Kajii syndrome) | |
TRPS1del | Trichorhinophalangeal syndrome, type II (TRPS2) (Langer-Giedion syndrome (LGS)) (Chromosome 8q24.1 deletion syndrome) |
TRPS2+del (offiz. EXT1) | Chondrosarcoma (CHDSA) |
Exostoses, multiple, type 1 (EXT1) (=Osteochondromas, multiple) | |
Langer-Giedion syndrome (LGS) (Trichorhinophalangeal syndrome, type II (TRPS2)) | |
TRPV4 | Brachyolmia type 3 (BRAC3) |
Hereditary motor and sensory neuropathy, type IIc (HMSN2C) | |
Metatropic dysplasia (MTD) | |
Parastremmatic dwarfism (PSTD) | |
Scapuloperoneal spinal muscular atrophy (SPSMA) | |
Spondyloepiphyseal dysplasia (SED), Maroteaux type (SEDM) (Pseudo-Morquio syndrome, type 2) | |
Sodium serum level QTL 1 (SSQTL1) (Hyponatremia) | |
Spinal muscular atrophy, distal, congenital nonprogressive (DSMAC) | |
Spondylometaphyseal dysplasia (SMD), Kozlowski type (SMDK) | |
TSC1+del | Focal cortical dysplasia of Taylor (FCDT) |
Focal cortical dysplasia of Taylor, type IIA | |
Lymphangioleiomyomatosis (LAM) (Lymphangiomatosis) | |
Tuberous sclerosis-1 (TSC1) | |
TSC2+del | Lymphangioleiomyomatosis, somatic |
Tuberous sclerosis-2 (TSC2) | |
TSPY1 (=TSPY) | Gonadoblastoma (GBY) |
TWIST1+del | Craniosynostosis, type 1 (CRS1) |
Saethre-Chotzen syndrome (SCS) (Acrocephalosyndactyly, type III (ACS3)) | |
Saethre-Chotzen syndrome with eyelid anomalies (Blepharophimosis, epicanthus inversus, and ptosis 3 (BPE3), formerly) | |
Scaphocephaly (Oxycephaly) |
Gen | Krankheit | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UBE3A+del | Angelman syndrome (AS) (happy puppet syndrome, formerly) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
USB1 (=C16orf57) | Poikiloderma with neutropenia (PN) (Poikiloderma with neutropenia, Clericuzio-type) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VAX1 | Anophthalmia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Microphthalmia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VEGFA | Microvascular complications of diabetes, susceptibility to, 1 (MVCD1) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VHL+del | Erythrocytosis, familial, 2 (ECYT2) (Polycythemia, Chuvash type) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hemangioblastoma, cerebellar, somatic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pheochromocytoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Renal cell carcinoma, somatic (RCC) (Hypernephroma) (Adrenocarcinoma of kidney) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
von Hippel-Lindau syndrome (VHLS) (von Hippel-Lindau disease (VHLD)) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VLCAD (offiz. ACADVL) | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WDR34 | Asphyxiating thoracic dystrophy (Jeune syndrome) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short rib-polydactyly syndrome, type III (SRPS3) (Verma-Naumoff syndrome) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WDR35+del | Cranioectodermal dysplasia 2 (CED2) (Sensenbrenner syndrome) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short rib-polydactyly syndrome, type V (SRPS5) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WDR60 | Short rib-polydactyly syndrome, type VI (SRPS6) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WFS1+del | Diabetes mellitus, noninsulin-dependent (NIDDM), association with | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deafness, autosomal dominant 6/14/38 (DFNA6/14/38) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Wolfram syndrome 1 (WFS1) (Diabetes insipidus and mellitus with optic atrophy and deafness (DIDMOAD)) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Wolfram-like syndrome, autosomal dominant (WFSL) (Hearing loss, progressive, with optic atrophy and/or impaired glucose regulation) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WISP3 | Arthropathy, progressive pseudorheumatoid, of childhood (PPAC) (Progressive pseudorheumatoid dysplasia (PPD)) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WNT1 | Osteogenesis imperfecta | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WNT4 | Mullerian aplasia and hyperandrogenism (MULLAPL) (Mullerian duct failure and hyperandrogenism) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SERKAL syndrome (46,XX sex reversal with dysgenesis of kidneys, adrenals, and lungs (SERKAL)) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WNT7A | Fuhrmann syndrome (FUHRS) (Fibular aplasia or hypoplasia femoral bowing and poly- syn- and oligodactyly) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ulna and fibula, absence of, with severe limb deficiency (Limb/pelvis-hypoplasia/aplasia syndrome (LPHAS)) (Al-Awadi/Raas-Rothschild syndrome (AARRS)) (Schinzel phocomelia syndrome) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WNT10A | Ectodermal dysplasia, hypohidrotic/anhidrotic | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Odontoonychodermal dysplasia (OODD) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schopf-Schulz-Passarge syndrome (SSPS) (Keratosis palmoplantaris with cystic eyelids, hypodontia, and hypotrichosis) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Succedaneous teeth, agenesis of | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tooth agenesis, selective, 4 (STHAG4) (Lateral incisors, pegged or missing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WNT10B | Split-hand/foot malformation 6 (SHFM6) (Ectrodactyly, autosomal recessive) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WRAP53 (= TCAB1) | Dyskeratosis congenita, autosomal recessive 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WT1+del | Denys-Drash syndrome (DDS) (Nephropathy, Wilms tumor, and genital anomalities) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Desmoplastic small round cell tumor (DSRCT) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Frasier syndrome (FS) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Meacham syndrome (MEACHS) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mesothelioma, somatic (MESOM) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nephrotic syndrome, type 4 (NPHS4) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WAGR (Wilms tumor, aniridia, genitourinary anomalies, and mental retardation) syndrome (Chromosome 11p13 deletion syndrome) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Wilms tumor, type 1 (WT1) (Nephroblastoma) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
XPB (offiz. ERCC3) | Ichthyosiform erythroderma with hair abnormality and mental and growth retardation (Tay syndrome) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trichothiodystrophy, photosensitive (TTDP) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xeroderma pigmentosum, group B (XBP) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xeroderma pigmentosum/Cockayne syndrome (XPB/CS) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
XYLT1 | Desbuquois dysplasia Type 2"XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 | XYLT1 |
Pseudoxanthoma elasticum (PXE) (Gronblad-Strandberg syndrome), modifier of severity of | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short stature syndrome, autosomal recessive, with intellectual disability | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ZEB2+del | Mowat-Wilson syndrome (MWIS) |
Krankheit | Gen |
3M syndrome | CUL7, OBSL1, CCDC8, FBXW8 |
46,XX Gonadal dysgenesis, complete, SRY-positive | SRY |
46,XX sex reversal 1 (SRXX1) | SRY |
46,XX sex reversal with dysgenesis of kidneys, adrenals, and lungs (SERKAL) | WNT4 |
46,XX sex reversal, SRY-positive | SRY |
46,XX True hermaphroditism, SRY-positive | SRY |
46,XY Gonadal dysgenesis, complete | SRY |
46,XY gonadal dysgenesis, complete or partial, with or without adrenal failure | NR5A1 |
46,XY Gonadal dysgenesis, complete, SRY-related | SRY |
46,XY sex reversal (SRXY) | SRY, NR5A1 |
46,XY sex reversal, partial or complete, NR5A1-related | NR5A1 |
46,XY sex reversal, SRY-related | SRY |
46,XY True hermaphroditism, SRY-related | SRY |
Aarskog-Scott syndrome (AAS) | FGD1+del |
Abdominal aortic aneurysm | COL3A1+del |
Achondrogenesis IA (ACG1A) | TRIP11 |
Achondrogenesis Ib (ACG1B) | SLC26A2 (=DTDST) |
Achondrogenesis II (ACG2) | COL2A1+del |
Achondrogenesis, Houston-Harris type | TRIP11 |
Achondrogenesis, Langer-Saldino type | COL2A1+del |
Achondrogenesis, type 2, formerly | GDF5 (=CDMP1) |
Achondroplasia (ACH) | FGFR3 |
Acid-labile subunit, deficiency of (ALSD) | IGFALS |
Acrocallosal syndrome | KIF7 |
Acrocapitofemoral dysplasia (ACFD) | IHH |
Acrocephalopolysyndactyly type 2 (ACPS2) | RAB23 |
Acrocephalosyndactyly (ACS) | FGFR1+del (=KAL2), FGFR2+del, TWIST1+del |
Acrocephaly, skull asymmetry, and mild syndactyly | FGFR2+del, TWIST1+del |
Acro-dermato-ungual-lacrimal-tooth (ADULT) syndrome | TP63 (=p63) |
Acrodysostosis, with or without hormone resistance (ACRDYS) | PRKAR1A+del, PDE4D |
Acrofacial dysostosis, type Weyers | EVC (=EVC1)+del, EVC2+del |
Acromesomelic chondrodysplasia with genital anomalies (AMDGA) | BMPR1B |
Acromesomelic dwarfism | GDF5 (=CDMP1) |
Acromesomelic dysplasia, Grebe type (AMDG) | GDF5 (=CDMP1) |
Acromesomelic dysplasia, Hunter-Thompson type (AMDH) | GDF5 (=CDMP1) |
Acromesomelic dysplasia, Maroteaux type (AMDM) | NPR2 |
Acromicric dysplasia (ACMICD) | FBN1+del |
Acropachy, hereditary | HPGD |
Acyl-CoA dehydrogenase medium chain deficiency (ACADM) | ACADM (=MCAD)+del |
Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) | ACADVL (=VLCAD) |
Adenocarcinoma of lung, somatic | BRAF |
Adenoma, periampullary, somatic | APC+del+dup |
Adenomas, salivary gland pleomorphic (PSA; SGPA) | CTNNB1; LIFR |
Adenomatous polyposis coli, familial (FAP) | APC+del+dup |
Adrenal hyperplasia, congenital, due to cytochrome P450 oxidoreductase deficiency | POR+del |
Adrenocarcinoma of kidney | VHL+del |
Adrenocortical insufficiency | NR5A1 |
Adrenocortical nodular dysplasia, primary | PRKAR1A+del |
Adrenocortical tumor, somatic | PRKAR1A+del |
ADULT syndrome (= Acro-dermato-ungual-lacrimal-tooth syndrome) | TP63 (=p63) |
AEC syndrome | TP63 (=p63) |
AEG syndrome | SOX2+del |
Aganglionic megacolon (MGC) | EDN3 |
AGAT deficiency | GATM |
Alagille syndrome, type 1 (ALGS1) | JAG1+del+dup |
Al-Aqeel Sewairi syndrome | MMP14, MMP2 |
Al-Awadi/Raas-Rothschild syndrome (AARRS) | WNT7A |
Albright hereditary osteodystrophy-like syndrome | HDAC4+del |
Allan-Herndon syndrome | SLC16A2 (=MCT8)+del |
Allan-Herndon-Dudley syndrome (AHDS) | SLC16A2 (=MCT8)+del |
Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity (T-CMVA) | RAG1+del |
Alpha-Galactosidase A deficiency | GLA+del |
Alpha-thalassemia myelodysplasia syndrome (ATMDS) | ATRX+del+dup |
Alpha-thalassemia/mental retardation syndrome, nondeletion type | ATRX+del+dup |
Alpha-thalassemia/mental retardation syndrome, X-linked (ATRX) | ATRX+del+dup |
Alport syndrome | COL4A5, COL4A3, COL4A4 |
Alport syndrome and diffuse leiomatosis (ATS-DL) | COL4A5+del |
Amyotrophy, neurogenic scapuloperoneal, New England type | TRPV4 |
Anauxetic dysplasia | RMRP, POP1 |
Anderson-Fabry disease | GLA+del |
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities ( XLANP) | GATA1 |
Aneurysm, abdominal aortic (AAA) | COL3A1+del |
Aneurysm, aortic and cerebral, with arterial tortuosity and skeletal manifestations | TGFB2+del |
Aneurysms-osteoarthritis syndrome | SMAD3 |
Angelman syndrome (AS) | UBE3A+del |
Angelman syndrome-like | MECP2+del, CDKL5+del+dup |
Angioedema, hereditary, type I+II (HAE1+2) | SERPING1 (=C1NH)+del |
Angiokeratoma corporis diffusum | GLA+del |
Angioneurotic edema, hereditary (HANE) | SERPING1 (=C1NH)+del |
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps (HANAC) | COL4A1, COL4A2 |
Aniridia (AN) | PAX6+del |
Aniridia II (AN2), formerly | PAX6+del |
Aniridia, cerebellar ataxia, and mental deficiency (ACAMD) | PAX6+del |
Aniridia, cerebellar ataxia, and mental retardation (ACAMR) | PAX6+del |
Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) | TP63 (=p63) |
Anophthalmia | VAX1 |
Anophthalmia, clinical, with associated anomalies | SOX2+del |
Anophthalmia-esophageal-genital (AEG) syndrome | SOX2+del |
Antibody deficiency and immune dysregulation, PLACG2-associated (PLAID) | PLCG2del |
Antley-Bixler syndrome (ABS) | POR+del, FGFR2+del |
Antoplo disease | LAMP2+del |
Anus, imperforate, with hand, foot, and ear anomalies | SALL1+del |
Aortic aneurysm and dissection, familial thoracic (TAAD) | MYH11+dup |
Aortic aneurysm, ascending, and dissection | FBN1+del |
Aortic aneurysm, familial abdominal 1 (AAA1) | COL3A1+del, TGFBR2, MYH11+dup, TGFBR1+dup, ACTA2, MYLK |
Aortic dissection, familial, with or without aortic aneurysm | MYLK |
Aortic stenosis, calcific | NOTCH1+del |
Aortic valve disease | NOTCH1+del |
Aortic valve disease 1 (AOVD1) | NOTCH1+del |
Aortic valve, bicuspid | NOTCH1+del |
Aortic valve, calcification of | NOTCH1+del |
Apert syndrome (APRS) | FGFR2+del |
Aplasia of lacrimal and salivary glands (ALSG) | FGF10+del |
Aplastic anemia, susceptibility to (AA) | TERC+del, TERT+del |
APOC2 deficiency | APOC2+del |
Apolipoprotein C-II deficiency | APOC2+del |
Arginine:glycine amidinotransferase deficiency | GATM |
Arthrochalasis multiplex congenita | COL1A2+del |
Arthrogryposis multiplex congenita, distal, type 1 (AMCD1) | TPM2 |
Arthrogryposis multiplex congenita, distal, type 2B (AMCD2B) | TNNT3, TNNI2, MYH3, TPM2 |
Arthrogryposis multiplex congenita, distal, type II, with craniofacial abnormalities | TNNT3, TNNI2, TPM2 |
Arthrogryposis, distal, type 1 (DA1) | TPM2 |
Arthrogryposis, distal, type 1A (DA1A) | TPM2 |
Arthrogryposis, distal, type 2A (DA2A) | MYH3 |
Arthrogryposis, distal, type 2B (DA2B) | TNNT3, TNNI2, MYH3, TPM2 |
Arthrogryposis, distal, type 9 (DA9) | FBN2 |
Arthroophthalmopathy, hereditary progressive (AOM) | COL2A1+del |
Arthropathy, progressive pseudorheumatoid, of childhood (PPAC) | WISP3 |
Asphyxiating thoracic dystrophy | WDR34, IFT80, DYNC2H1 |
Asplenia, familial | RPSA (= LAMR1) |
Asplenia, isolated congenital (ICAS) | RPSA (= LAMR1) |
Ataxia with lactic acidosis II | PC |
Ateliotic dwarfism with hypogonadism | PROP1+del |
Atelosteogenesis (AO) | FLNB, SLC26A2 (=DTDST) |
Athabaskan brainstem dysgenesis syndrome (ABSD) | HOXA1 |
Atopy | SPINK5 |
ATR, nondeletion type | ATRX+del+dup |
Atrial myxoma, familial | PRKAR1A+del |
Atrial septal defect (ASD) | GATA4+del, NKX2-5 |
Atriodigital dysplasia | TBX5+del+dup |
Atrioventricular septal defect (AVSD) | GATA4+del, CRELD |
ATR-X syndrome | ATRX+del+dup |
Atypical mycobacterial infection, disseminated, X-linked type 1 | IKBKG (=NEMO)+del |
Atypical mycobacteriosis, familial (AMCBX1) | IKBKG (=NEMO)+del |
Autism susceptibility, X-linked 3 (AUTSX3) | MECP2+del |
Autonomic control, congenital failure of | EDN3 |
Avascular necrosis of the femoral head (ANFH) | COL2A1+del |
Axenfeld-Rieger syndrome (ARS) | PITX2+del |
Krankheit | Gen |
Bannayan-Riley-Ruvalcaba syndrome (BRRS) | PTEN+del |
Bannayan-Zonana syndrome (BZS) | PTEN+del |
Baraitser-Burn syndrome | TCTN3 |
Barraquer-Simons syndrome | LMNB2 |
Bart-Pumphrey syndrome (BPS) | GJB2 (=CX26) |
Basal cell carcinoma, somatic (BCC) | PTCH1+del, PTCH2 |
Basal cell nevus syndrome (BCNS) | PTCH1+del |
Beals syndrome | FBN2 |
Beare-Stevenson cutis gyrata syndrome (BSTVS) | FGFR2+del |
Beckwith-Wiedemann syndrome (BWS) | CDKN1C+dup; NSD1 (=SOTOS)+del |
Benign hypermobility syndrome | COL3A1+del |
Berardinelli syndrome | BSCL2+del |
Berardinelli-Seip congenital lipodystrophy (BSCL) | AGPAT2+del, BSCL2+del, CAV1, PTRF |
Beta-Galactosidase-1 (GLB1) deficiency | GLB1+del+dup |
Bicuspid aortic valve (BAV) | NOTCH1+del |
Bile acid synthesis defect, congenital, 3 (CBAS3) | CYP7B1 |
Biodefective growth hormone | GH1+del+dup |
Blackfan-Diamond Syndrome; BDS | Phase 1: Sequenzierung RPS19, RPL5, RPL11, RPS26, RPL35a Phase 2: Deletionsanalyse der RP-Gene mittels Array-CGH Phase 3: Sequenzierung RPS10, RPS24, RPS7, RPL15, RPL26, RPL15, GATA1 |
Bladder cancer, somatic (BLC) | KRAS, FGFR3, HRAS |
Blepharophimosis, epicanthus inversus, and ptosis | FOXL2+del+dup, TWIST1+del |
Blepharophimosis-mental retardation syndrome, Maat-Kievit-Brunner type | MED12 |
Bohring-Opitz syndrome | CD96 |
Bone marrow failure, familial (BMFF) | SRP72 |
Bone marrow failure, telomere-related, 1 | TERT |
Bone modeling defect of hands and feet | PTH1R (= PTHR) |
Boomerang dysplasia | FLNB |
Bosley-Salih-Alorainy syndrome (BSAS) | HOXA1 |
Brachydactyly, Haws type | GDF5 (=CDMP1) |
Brachydactyly, type A1 (BDA1) | IHH |
Brachydactyly, type A2 (BDA2) | GDF5 (=CDMP1), BMP2+del+dup, BMPR1B |
Brachydactyly, type B2 (BDB2) | NOG |
Brachydactyly, type C (BDC) | GDF5 (=CDMP1) |
Brachydactyly, type D (BDD) | HOXD13+del |
Brachydactyly, type E (BDE) | HOXD13+del |
Brachydactyly, type E1 (BDE1) | HOXD13+del |
Brachydactyly-mental retardation syndrome (BDMR) | HDAC4+del |
Brachydactyly-syndactyly syndrome (BDSD) | HOXD13+del, MBOAT1+del |
Brachymelic primordial dwarfism | RNU4ATAC |
Brachymesophalangy II | GDF5 (=CDMP1), BMP2+del+dup, BMPR1B |
Brachyolmia, autosomal dominant | TRPV4 |
Brachyolmia, autosomal recessive | PAPSS2 |
Brachyrachia | TRPV4 |
Brain small vessel disease with Axenfeld-Rieger anomaly | COL4A1, COL4A2 |
Brain small vessel disease with hemorrhage (BSVDH) | COL4A1, COL4A2 |
Brain tumor, posterior fossa, of infancy, familial) | SMARCB1 (=INI1)+del |
Brain tumor-polyposis syndrome 1 (BTPS1 | MLH1+del, MSH2+del, MSH6+del, PMS2+del |
Brain tumor-polyposis syndrome 2 | APC+del+dup |
Breast cancer, somatic (BC) | KRAS, AKT1 |
Bruck syndrome 2 (BRKS2) | PLOD2 |
Brunzell syndrome | AGPAT2+del, BSCL2+del |
Budd-Chiari syndrome, susceptibility to (BDCHS) | JAK2 |
Bulldog syndrome | GPC3+del, GPC4del+dup |
Krankheit | Gen |
C syndrome (CSYN) | CD96 |
C1 esterase inhibitor, deficiency of | SERPING1 (=C1NH)+del |
C8 beta deficiency | C8B |
C8 deficiency, type II | C8B |
C8B deficiency | C8B |
Cafe-au-lait spots with glioma or leukemia | MLH1+del |
Cafe-au-lait spots with pulmonic stenosis | NF1+del |
Cafe-au-lait spots, multiple, with leukemia (DD zu MMRCS) | MSH2+del |
Caffey disease (CAFFD) | COL1A1+del |
Calcinosis, tumoral, with hyperphasphatemia | FGF23 |
Camptodactyly tall stature and hearing loss (CATSHL) syndrome | FGFR3 |
Cardiofaciocutaneous syndrome (CFCS) | BRAF, KRAS, MAP2K1 (=MEK1), MAP2K2 (=MEK2) |
Cardiogenital syndrome | LMNA+del |
Cardiomyopathy, congestive, with hypergonadotropic hypogonadism | LMNA+del |
Cardiomyopathy, dilated | LMNA+del, TNNI3, TPM1 |
Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | LMNA+del |
Cardiomyopathy, dilated, with premature ovarian failure | LMNA+del |
Cardiomyopathy, dilated, with primary testicular failure | LMNA+del |
Cardiomyopathy, familial hypertrophic | TPM1, TNNI3 |
Carney complex, type 1 (CNC1) | PRKAR1A+del |
Carney myxoma-endocrine complex | PRKAR1A+del |
Carney syndrome (CAR) | PRKAR1A+del |
Carnitine palmitoyltransferase 2 deficiency, infantile (CPT2DI) | CPT2 |
Carnitine palmitoyltransferase 2 deficiency, late-onset (CPT2D) | CPT2 |
Carnitine palmitoyltransferase 2 deficiency, lethal neonatal (CPT2D-LN) | CPT2 |
Carpenter syndrome (CARPS) | RAB23 |
Carpenter-Waziri syndrome (CWS) | ATRX+del+dup |
Cartilage-hair hypoplasia (CHH) | RMRP |
Cartilage-hair hypoplasia variant, skeletal manifestations only (CHHV) | RMRP |
Cartilage-hair hypoplasia-like skeletal dysplasia without hypotrichosis or immunodeficiency | RMRP |
Cataract with late-onset corneal dystrophy | PAX6+del |
Catlin marks | MSX2+del |
CATSHL syndrome (= camptodactyly tall stature and hearing loss syndrome) | FGFR3 |
CBL syndrome | CBL |
Cchondrodystrophy with sensineural deafness | COL2A1+del, COL11A2 |
Central hypoventilation syndrome, congenital (CCHS) | EDN3 |
Cephaloskeletal dysplasia | RNU4ATAC |
Cerebelloparenchymal disorder VI (CPD6) | PTEN+del |
Cerebral creatine deficiency syndrome (CCDS) | SLC6A8+del, GAMT, GATM |
Cerebral gigantism | NSD1 (=SOTOS)+del, NFIX |
Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) | CTC1 |
Cervical cancer | TP63 (=p63) |
Cervical cancer, somatic (CERCA) | FGFR3 |
CFC syndrome | BRAF, KRAS, MAP2K1 (=MEK1), MAP2K2 (=MEK2) |
Charcot-Marie-Tooth disease | LMNA+del, TRPV4 |
Charcot-Marie-Tooth neuropathy | LMNA+del, TRPV4 |
CHARGE syndrome | CHD7 (=KAL5)+del |
Chondrodysplasia punctata, rhizomelic form (CDPR) | PEX7+del |
Chondrodysplasia punctata, X-linked dominant, 2 (CDPX2) | EBP (=CPX) |
Chondrodysplasia with joint dislocations, GPAPP type (CDP-GPAPP) | IMPAD1 |
Chondrodysplasia with multiple dislocations, CDMD | CHST3 (=C6ST1) |
Chondrodysplasia, Blomstrand type (BOCD) | PTH1R (= PTHR) |
Chondrodysplasia, Grebe type | GDF5 (=CDMP1) |
Chondrodystrophia calcificans punctata | PEX7+del |
Chondroectodermal dysplasia | EVC (=EVC1)+del, EVC2+del |
Chondrogenesis imperfecta | COL2A1+del |
Chondrosarcoma (CHDSA) | EXT1+del (=TRPS2), EXT2+del |
Chotzen syndrome | FGFR2+del, TWIST1+del |
Chromosome 10q23 deletion syndrome | BMPR1A+del, PTEN+del |
Chromosome 11p11.2 deletion Syndrome | EXT2+del, ALX4 |
Chromosome 11p13 deletion syndrome | PAX6del, WT1del |
Chromosome 11p13-p12 deletion syndrome | PAX6del, WT1del |
Chromosome 16p13.3 deletion syndrome | CREBBP+del |
Chromosome 2p16.3 deletion syndrome | NRXN1del |
Chromosome 2q37.2 deletion syndrome | HDAC4+del |
Chromosome 5q14.3 deletion syndrome | MEF2C del |
Chromosome 8q24.1 deletion syndrome | TRPS1del |
Chromosome Xq22.3 centromeric deletion syndrome | COL4A5del |
Chronic infantile neurologic cutaneous and articular syndrome (CINCA) | NLRP3 (=NALP3) |
Chronic neurologic cutaneous and articular syndrome | NLRP3 (=NALP3) |
Chronic recurrent multifocal osteomyelitis (CRMO), congenital dyserythropoietic anemia (CDA), and neutrophilic dermatosis (Sweet syndrome) | LPIN2 |
Chudley-Lowry syndrome | ATRX+del+dup |
Chylomicronemia, familial | LPL+del+dup |
C-II Anapolipoproteinemia | APOC2+del |
CINCA syndrome | NLRP3 (=NALP3) |
Cleft lip and/or palate with mucous cysts of lower lip | IRF6+del |
Cleft lip with or without cleft palate, nonsyndromic (CL/P) | BMP4, IRF6+del, TP63 (=p63) |
Cleft lip/palate, paramedian mucous cysts of the lower lip, popliteal pterygium, digital and geneital anomalies faciogenitopopliteal syndrome | IRF6+del |
Cleidocranial dysostosis (CLCD) | RUNX2+del |
Cleidocranial dysplasia (CCD) | RUNX2+del |
Cleidocranial dysplasia with parietal foramina | MSX2+del |
C-like syndrome (CLSYN) | CD96 |
Clubbing of digits | HPGD |
Coats plus syndrome | CTC1 |
Coffin-Lowry syndrome (CLS) | RPS6KA3 (=RSK2) +del+dup |
Cold autoinflammatory syndrome, familial (FCAS) | NLRP3 (=NALP3), NLRP12 (=NALP12) |
Cold urticaria, familial (FCU) | NLRP3 (=NALP3) |
Cold-induced autoinflammatory syndrome, familial (FCAS) | NLRP3 (=NALP3) |
Coloboma of iris, choroid, and retina (COI) = Coloboma, uveoretinal) | PAX6+del |
Coloboma of optic nerve (COLON) | PAX6+del |
Coloboma of optic nerve with renal disease | PAX2+del |
Coloboma, ocular (COLO) | PAX6+del |
Coloboma, uveoretinal | PAX6+del |
Colorectal cancer (CRC) | CTNNB1, TP63 (=p63), EP300+del, SMAD4 |
Colorectal cancer, hereditary nonpolyposis (HNPCC) | MSH2+del, MLH1+del, PMS2+del, MSH6+del, TGFBR2+del, MLH3 |
Colorectal cancer, somatic (CRC) | MLH3, AKT1, APC, BRAF |
Combined cellular and humoral immune defects with granulomas (CCHIDG) | RAG1+del, RAG2+del |
Combined immunodeficiency with susceptibility to mycobacterial, viral, and fungal infections | GATA2 |
Commissural cleft, isolated | PTCH2 |
Complement component 4 (C4), partial deficiency of | SERPING1 (=C1NH)+del |
Complement component 8 deficiency, type II (C8D2) | C8B |
Complement component 8B deficiency | C8B |
Complex I deficiency, mitochondrial | ECSIT |
Congenital 'healed' cleft lip (CHCL) | BMP4 |
Congenital hypothalamic hamartoma syndrome (CHHS) | GLI3+del+dup |
Congenital mydriasis | ACTA2 |
Conotruncal anomaly face syndrome (CAFS) | NKX2-5 |
Conotruncal heart malformations, variable (CTHM) | NKX2-5 |
Conradi-Hunermann-Happle syndrome | EBP (=CPX) |
Contractural arachnodactyly, congenital (CCA) | FBN2 |
Copper transport disease | ATP7A+del+dup |
Cornelia de Lange syndrome (CDLS) | NIPBL+del, SMC1A (=SMC1L1)+del+dup , SMC3 |
Coronary artery disease | TERT |
Coronary artery disease, susceptiblity to (CAD) | TERT+del |
Corpus callosum, agenesis of (ACC), with abnormal genitalia | ARX+del+dup |
Cortical dysplasia of Taylor (CDT) | TSC1+del |
Cortical dysplasia of Taylor with balloon cells (CDTBC) | TSC1+del |
Cortical dysplasia of Taylor without balloon cells | TSC1+del |
Cortical dysplasia of Taylor, dysplasia only (CDTD) | TSC1+del |
Cortical hyperostosis with hyperphosphatemia | FGF23 |
Costello syndrome | HRAS |
Cousin syndrome (COUSS) | TBX15 |
Cowden disease (CD) | PTEN+del |
Cowden syndrome (CS) | PTEN+del |
CPT deficiency, hepatic, type II | CPT2 |
CPT II deficiency, lethal neonatal | CPT2 |
CPT II deficiency, myopathic | CPT2 |
Craniodiaphyseal dysplasia, autosomal dominant (CDD) | SOST |
Cranioectodermal dysplasia (CED) | IFT122, WDR35+del, IFT43 |
Craniofacial dysmorphism, hypoplasia of scapula and pelvis, and short stature | TBX15 |
Craniofacial dysostosis type I (CFD1) | FGFR2+del |
Craniofacial-deafness-hand syndrome (CDHS) | PAX3+del |
Craniofacial-skeletal-dermatologic dysplasia | FGFR2+del |
Craniofrontonasal dysostosis | EFNB1+del+dup |
Craniofrontonasal dysplasia (CFND) | EFNB1+del+dup |
Craniofrontonasal syndrome (CFNS) | EFNB1+del+dup |
Craniomandibular dermatodysostosis | LMNA+del |
Cranioosteoarthropathy (COA) | HPGD |
Craniostenosis | FGFR2+del, TWIST1+del, MSX2+del |
Craniosynostosis (CRS) | FGFR2+del, TWIST1+del, MSX2+del |
Craniosynostosis with arachnodyctyly and abdominal hernias | SKI |
Craniosynostosis, metopic | FGFR1+del (=KAL2) |
Craniosynostosis, midfacial hypoplasia, and foot anomalies | FGFR1+del (=KAL2), FGFR2+del |
Cranium bifidum occultum | MSX2+del |
Cranium bifidum, hereditary | MSX2+del |
Creatine deficiency syndrome due to AGAT deficiency | GATM |
Creatine deficiency syndrome due to GAMT deficiency | GAMT |
Creatine deficiency syndrome, X-linked | SLC6A8+del |
Creatine transporter defect | SLC6A8+del |
Crossed polydactyly, type I (CP1) | GLI3+del+dup |
Crouzon syndrome (CS) | FGFR2+del |
Crouzon syndrome with acanthosis nigricans | FGFR3 |
Cryopyrin-associated periodic syndrome (CAPS) | NLRP3 (=NALP3) |
Currarino idiopathic osteoarthropathy (CIO) | HPGD |
Curry-Hall syndrome | EVC (=EVC1)+del, EVC2+del |
Cushing symphalangism | GDF5 (=CDMP1), NOG |
Cushing syndrome, adrenal, due to PPNAD1 | PRKAR1A+del |
Cutis laxa with progeroid features | PYCR1+del |
Cutis laxa, autosomal dominant, 1 (ADCL1) | ELN+del |
Cutis laxa, autosomal recessive (ARCL) | ATP6V0A2+del, PYCR1+del |
Cutis laxa, X-linked, formerly | ATP7A+del+dup |
Cytochrome P450 oxidoreductase deficiency | POR+del |
Czech dysplasia | COL2A1+del |
Krankheit | Gen |
D-2-Hydroxyglutaric aciduria (D2HGA) | D2HGDH+del, IDH2 |
Danon disease (DAND) | LAMP2+del |
Dappled metaphysis syndrome | COL2A1+del |
D-bifunctional protein deficiency (DBPD) | HSD17B4+del (= DBP) |
De Barsy Syndrome B | PYCR1+del |
De la Chapelle dysplasia (DLCD) | SLC26A2 (=DTDST) |
Deafness, autosomal dominant (DFNA) | GJB2 (=CX26), WFS1+del, COL11A2, MYO6 |
Deafness, autosomal dominant 22 (DFNA22), with hypertrophic cardiomyopathy | MYO6 |
Deafness, autosomal recessive | GJB2 (=CX26), MYO6, COL11A2 |
Deafness, congenital heart defects, and posterior embryotoxon | JAG1+del+dup |
Deafness, sensorineural, with imperforate anus and thumb anomalies | SALL1+del |
Defect11 syndrome | EXT2+del, ALX4 |
Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency (DCML) | GATA2 |
Dental anomalies, isolated | RUNX2+del |
Dental noneruption | PTH1R (= PTHR) |
Denys-Drash syndrome (DDS) | WT1+del |
Dermatopathia pigmentosa reticularis (DPR) | KRT14 |
Desbuquois dysplasia (DBQD) | CANT1+del, XYLT1 |
Desmoid disease, hereditary (HDD) | APC+del+dup |
Desmoplastic small round cell tumor (DSRCT) | WT1+del |
Developmental delay, epilepsy, and neonatal diabetes (DEND) | KCNJ11 |
Diabetes insipidus and mellitus with optic atrophy and deafness (DIDMOAD) | WFS1+del |
Diabetes mellitus, noninsulin-dependent (NIDDM) | ABCC8+del |
Diabetes mellitus, noninsulin-dependent (NIDDM), association with | WFS1 |
Diabetes mellitus, permanent neonatal (PNDM) | ABCC8+del, KCNJ11 |
Diabetes mellitus, permanent neonatal, with neurologic features | KCNJ11 |
Diabetes mellitus, permanent, of infancy (PDMI) | ABCC8+del, KCNJ11 |
Diabetes mellitus, transient neonatal | ABCC8+del, KCNJ11 |
Diamond-Blackfan Anemia (DBA) | Phase 1: Sequenzierung RPS19, RPL5, RPL11, RPS26, RPL35a Phase 2: Deletionsanalyse der RP-Gene mittels Array-CGH Phase 3: Sequenzierung RPS10, RPS24, RPS7, RPL15, RPL26, RPL15, GATA1 |
Diastrophic dysplasia (DTD) | SLC26A2 (=DTDST) |
Diastrophic dysplasia, broad bone-platyspondylic variant (DTDB) | SLC26A2 (=DTDST) |
Digital clubbing, isolated congenital | HPGD |
Dihydrolipoamide dehydrogenase deficiency (DLDD) | DLD (=LAD) |
Disorder of sex development, 46,XY | NR5A1 |
Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) | POR+del |
Disordered steroidogenesis due to POR deficiency | POR+del |
DLD deficiency | DLD (=LAD) |
Double-outlet right ventricle (DORV) | NKX2-5 |
Drash syndrome | WT1+del |
Du Pan syndrome (DPS) | GDF5 (=CDMP1) |
Dwarfism of Sindh | GHRHR, GH1+del+dup |
Dyggve-Melchior-Clausen disease (DMC) | DYM+dup |
Dyschondroplasia | IDH1, IDH2, PTH1R (= PTHR) |
Dyschondrosteosis (DCO) | SHOX+del |
Dyschondrosteosis, homozygous | SHOX+del |
Dyskeratosis congenita | DKC1, TRC, TERT, TINF2, RTEL1, NOP10, NHP2, CTC1, C16orf57 |
Dysplasia gigantism syndrome, X-linked (DGSX) | GPC3+del, GPC4del+dup |
Dysplastic gangliocytoma of the cerebellum | PTEN+del |
Dyssegmental dysplasia, Silverman-Handmaker type (DDSH) | HSPG2+del |
Krankheit | Gen |
E3 deficiency | DLD (=LAD) |
Eccrine tumors with ectodermal dysplasia | WNT10A |
Ectodermal dysplasia Rapp-Hodgkin type (EDRH) | TP63 (=p63) |
Ectodermal dysplasia, anhidrotic, with cleft lip/palate | TP63 (=p63) |
Ectodermal dysplasia, hypohidrotic/anhidrotic | WNT10A |
Ectodermal dysplasia, hypohidrotic/anhidrotic, with immune deficiency | IKBKG (=NEMO)+del |
Ectopia lentis, familial (EL) | FBN1+del |
Ectopia lentis, isolated, autosomal dominant | FBN1+del |
Ectopia pupillae | PAX6+del |
Ectrodactyly, autosomal recessive | WNT10B |
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) | TP63 (=p63) |
EEC syndrome 3 | TP63 (=p63) |
Ehlers-Danlos syndrome gravis | COL1A1+del |
Ehlers-Danlos syndrome type I (EDS1) | COL1A1+del |
Ehlers-Danlos syndrome type VII, autosomal dominant | COL1A1+del |
Ehlers-Danlos syndrome type VIIA (EDS7A) | COL1A1+del |
Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss (EDSKMH) | FKBP14 |
Ehlers-Danlos syndrome, arterial type | COL3A1+del |
Ehlers-Danlos syndrome, arthrochalasia type | COL1A1+del, COL1A2+del |
Ehlers-Danlos syndrome, cardiac valvular form (EDSCV) | COL1A2+del |
Ehlers-Danlos syndrome, ecchymotic type | COL3A1+del |
Ehlers-Danlos syndrome, gravis type | COL5A1+del+dup, COL5A2 |
Ehlers-Danlos syndrome, hypermobility type | COL3A1+del |
Ehlers-Danlos syndrome, kyphoscoliotic type | PLOD1+del+dup |
Ehlers-Danlos syndrome, mild classic type | COL5A1+del+dup |
Ehlers-Danlos syndrome, mitis type | COL5A1+del+dup |
Ehlers-Danlos syndrome, occipital horn type, formerly | ATP7A+del+dup |
Ehlers-Danlos syndrome, ocular-scoliotic type | PLOD1+del+dup |
Ehlers-Danlos syndrome, progeroid form (EDSP) | B4GALT7, B3GALT6 |
Ehlers-Danlos syndrome, Sack-Barabas type | COL3A1+del |
Ehlers-Danlos syndrome, severe classic type | COL5A1+del+dup, COL5A2 |
Ehlers-Danlos syndrome, type I (EDS I) (EDS1) | COL5A1+del+dup, COL5A2 |
Ehlers-Danlos syndrome, type II (EDS II) (EDS2) | COL5A1+del+dup |
Ehlers-Danlos syndrome, type III (EDSIII; EDS3) | COL3A1+del |
Ehlers-Danlos syndrome, type IV, autosomal dominant (EDS IV; EDS4) | COL3A1+del |
Ehlers-Danlos syndrome, type IX (EDS IX) (EDS9), formerly | ATP7A+del+dup |
Ehlers-Danlos syndrome, type VI (EDS6) (EDS VI) | PLOD1+del+dup |
Ehlers-Danlos syndrome, type VIA, formerly (EDS6A, formerly) | PLOD1+del+dup |
Ehlers-Danlos syndrome, type VIIB (EDS7B) | COL1A2+del |
Ehlers-Danlos syndrome, vascular type | COL3A1+del |
Eiken skeletal dysplasia (EISD) | PTH1R (= PTHR) |
Eiken syndrome | PTH1R (= PTHR) |
Ellis-van Creveld syndrome (EVC) | EVC (=EVC1)+del, EVC2+del |
Emberger syndrome | GATA2 |
Emery-Dreifuss muscular dystrophy (EDMD) (EMD) | LMNA+del |
Encephalopathy, acute, infection-induced, 4, susceptibility to (IIAE4) | CPT2 |
Encephalopathy, neonatal severe | MECP2+del |
Enchondromatosis, multiple, Ollier type (ENCHOM) | IDH1, IDH2, PTH1R (= PTHR) |
Endometrial cancer (ENDMC), susceptibility to | MLH1+del, MSH2+del |
Endometrial cancer, familial (ENDMC) | MLH3, MSH6+del |
Endometrial cancer, somatic (ENDMC) | PTEN+del |
Enlarged vestibular aqueduct (EVA) | FOXI1 |
Epidermal nevus syndrome, formerly | KRAS |
Epidermolysis bullosa simplex Dowling-Meara type (EBS-DM) | KRT14 |
Epidermolysis bullosa simplex Koebner type (EBS-K) | KRT14 |
Epidermolysis bullosa simplex Weber-Cockayne type (EBS-WC) | KRT14 |
Epidermolysis bullosa simplex, autosomal recessive (AREBS) | KRT14 |
Epidermolysis bullosa simplex, generalized (EBS generalized) | KRT14 |
Epidermolysis bullosa simplex, localized | KRT14 |
Epileptic encephalopathy, early infantile (EIEE) | ARX+del+dup, CDKL5+del+dup |
Epiphyseal dysplasia, Fairbank type (EDMF) | COMP+del |
Epiphyseal dysplasia, multiple, autosomal dominant (EDM) | COMP+del, MATN3, COL9A1, COL9A2, COL9A3 |
Epiphyseal dysplasia, multiple, autosomal recessive (EDM) | SLC26A2 (=DTDST) |
Epiphyseal dysplasia, multiple, with myopia and deafness (EDMMD) | COL2A1+del |
Epiphyseal dysplasia, Ribbing type (EDMR) | COMP+del |
Erythrocytosis, autosomal recessive benign | VHL+del |
Erythrocytosis, familial, 2 (ECYT2) | VHL+del |
Erythrocytosis, somatic | JAK2 |
Esophageal cancer, somatic | TGFBR2 |
ESS1, formerly | TGFBR1+dup |
ETFA deficiency | ETFA+del |
ETFB deficiency | ETFB |
ETFDH deficiency | ETFDH |
Ethylmalonic-adipicaciduria (EMA) | ETFA+del, ETFB |
Eunuchoidism, familial hypogonadotropic | GNRH1 |
Ewing sarcoma (ES) | FLI1 |
Exomphalos-Makroglossia-Gigantism syndrome (EMGS) | CDKN1C+dup; NSD1 (=SOTOS)+del |
Exostoses, multiple, type (EXT) | EXT1+del (=TRPS2), EXT2+del |
Exudative retinopathy with bone marrow failure (ERBMF) | TINF2 |
Krankheit | Gen |
Fabry disease | GLA+del |
Fabry disease, cardiac variant | GLA+del |
Facioauriculovertebral sequence (FAVS) | TCOF1+del |
Faciocutaneoskeletal syndrome (FCSS) | HRAS |
Faciogenital dysplasia (FGDY) | FGD1+del |
Failure of tooth eruption, primary (PFE) | PTH1R (= PTHR) |
Familial atypical cold urticaria (FACU) | PLCG2 (nur del) |
Familial cold autoinflammatory syndrome 3 (FCAS3) | PLCG2 (nur del) |
Familial combined hyperlipidemia | LPL+del+dup |
Familial idiopathic osteoarthropathy of childhood | HPGD |
Fanconi renotubular syndrome 2 (FRTS2) | SLC34A1 |
Female Pseudo-Turner syndrome | PTPN11+dup |
Ferguson-Smith type epithelioma | TGFBR1+dup |
Fertile eunuch syndrome | GNRHR |
Fetal hypokinesia sequence due to restrictive dermopathy | LMNA+del |
FG syndrome (FGS) | MED12 |
FG syndrome 1 (FGS1) | MED12 |
Fibrochondrogenesis | COL11A1+del |
Fibrodysplasia ossificans progressiva (FOP) | ACVR1 |
Fibromatosis, gingival, 1 (GINGF1) (GINGF) (GGF1) | SOS1 |
Fibromatosis, gingival, hereditary (HGF) | SOS1 |
Fibromyxoid sarcoma, low grade (LGFMS) | CREB3L2 |
Fibular aplasia or hypoplasia femoral bowing and poly- syn- and oligodactyly | WNT7A |
Fibular hypoplasia and complex brachydactyly | GDF5 (=CDMP1) |
Finlay-Marks syndrome | KCTD1 |
Floating-Harbor syndrome (FLHS) | SRCAP |
Focal cortical dysplasia of Taylor (FCDT) | TSC1+del |
Focal cortical dysplasia, type II | TSC1+del |
Focal dermal hypoplasia (FODH) | PORCN+del |
Folate malabsorption, hereditary (HFM) | SLC46A1 |
Foramina parietalia permagna (FPP) | ALX4, MSX2+del |
Foveal hypoplasia and presenile cataract syndrome | PAX6+del |
Foveal hypoplasia with anterior segment anomalies or isolated | PAX6+del |
Frasier syndrome (FS) | WT1+del |
Freeman-Sheldon syndrome (FSS) | MYH3 |
Freeman-Sheldon syndrome variant (FSSV) | TNNT3, TNNI2, TPM2 |
Frontonasal dysplasia type 2 (FND2) | ALX4 |
Fructose intolerance, hereditary (HFI) | ALDOB+del |
Fuhrmann syndrome (FUHRS) | WNT7A |
Furlong syndrome | TGFBR1+dup |
Galactose-1-phosphate uridylyltransferase deficiency | GALT+del |
Galactosemia | GALT+del |
Galactosyltransferase I deficiency, XGPT deficiency | B4GALT7 |
GALT deficiency | GALT+del |
Gangliosidosis, generalized GM1 | GLB1+del+dup |
Gardner syndrome (GS) | APC+del+dup |
Gastric cancer, somatic | APC+del+dup, FGFR2+del, KRAS |
Gastrointestinal stromal tumor, familial (GIST) | KIT |
GATA2 deficiency (MonoMAC (monocytopenia, NK- and B- lymphocytopenia, severe infections with M. avium complex (MAC), and risk of progression to MDS/AML)) | GATA2 |
GATM deficiency | GATM |
Geleophysic dysplasia (GLPD) | ADAMTSL2, FBN1+del |
Genital anomaly with cardiomyopathy | LMNA+del |
Geroderma osteodysplastica | GORAB (=SCYL1BP1) |
Geroderma osteodysplasticum (GO) | GORAB (=SCYL1BP1) |
Giant cell chondrodysplasia | FLNB |
Gigantism, partial, of hands and feet, nevi, hemihypertrophy, and macrocephaly | AKT1, PTEN+del |
Gillespie syndrome (GS) | PAX6+del |
GLA deficiency | GLA+del |
Glioma (GLM) | IDH1 |
Glioma susceptibility 2 (GLM2) | PTEN+del |
Glutaric acidemia II (GA2) | ETFDH, ETFA+del, ETFB |
Glutaric acidemia IIA | ETFA+del |
Glutaric acidemia IIB | ETFB |
Glutaric acidemia IIC (GA2C) | ETFDH |
Glutaric aciduria II (GA2) | ETFDH, ETFA+del, ETFB |
Glutaric aciduria III (GA3) | C7orf10 |
Glutaryl-CoA oxidase deficiency | C7orf10 |
Glycogen storage disease Ia (GSD1A) | G6PC |
Glycogen storage disease type 2B (GSD2B), formerly | LAMP2+del |
GM1-gangliosidosis | GLB1+del+dup |
Golabi-Rosen syndrome | GPC3+del, GPC4del+dup |
Goldblatt syndrome | N.N. |
Goldenhar syndrome | TCOF1+del |
Goltz syndrome | PORCN+del |
Goltz-Gorlin syndrome | PORCN+del |
Gonadoblastoma (GBY) | TSPY1 (=TSPY) |
Gonadotropin deficiency, familial idiopathic (FIGD) | GNRH1 |
Gorlin syndrome | PTCH1+del |
Gorlin-Goltz syndrome | PTCH1+del |
Greig cephalopolysyndactyly syndrome (GCPS) | GLI3+del+dup |
Gronblad-Strandberg syndrome, modifier of severity of | XYLT1 |
Growth hormone deficiency with pituitary anomalies | HESX1+del |
Growth hormone deficiency, isolated | GHRHR, GH1+del+dup |
Growth-mental deficiency syndrome of Myhre | SMAD4 |
Guanidinoacetate methyltransferase (GAMT) deficiency | GAMT |
Krankheit | Gen |
Hamartomas, pulmonary chondroid | HMGA2 |
HANAC syndrome (Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps) | COL4A1, COL4A2 |
Hanhart dwarfism | PROP1+del |
Happy puppet syndrome, formerly | UBE3A+del |
Hauptmann-Thannhauser muscular dystrophy | LMNA+del |
Hay-Wells syndrome | TP63 (=p63) |
Head cancer | TP63 (=p63) |
Hearing loss, non-syndromic | COL9A3 |
Hearing loss, progressive, with optic atrophy and/or impaired glucose regulation | WFS1+del |
Heart-hand syndrome | TBX5+del+dup |
Heart-hand syndrome, Slovenian type | LMNA+del |
Hemangioblastoma, cerebellar, somatic | VHL+del |
Hemangioma, capillary infantile, susceptibility to (HCI) | ANTXR1 (=TEM8) |
Hemangiomatosis | FLI1 |
Hematuria, benign familial (BFH) | COL4A3, COL4A4 |
Hemifacial microsomia (HFM) | TCOF1+del |
Hemiparesis, and leukoencephalopathy, autosomal dominant | COL4A1, COL4A2 |
Hemiplegia, infantile, with porencephaly, type 1 (T1P) | COL4A1 |
Hemoglobin H disease, acquired | ATRX+del+dup |
Hepatoblastoma | CTNNB1 |
Hepatoblastoma, somatic | APC+del+dup |
Hepatocellular carcinoma (HCC) | CTNNB1 |
Hereditary absence of the proximal interphalangeal (PIP) joints | GDF5 (=CDMP1), NOG |
Hereditary motor and sensory neuropathy, type IIc (HMSN2C) | TRPV4 |
Heredopathia atactica polyneuritiformis | PEX7+del |
HFE hemochromatosis, modifier of | BMP2+del+dup |
Hippel-Lindau disease (VHLD) | VHL+del |
Hirschsprung disease, susceptibility to, 4 (HSCR4) | EDN3 |
Holmes-Gang syndrome | ATRX+del+dup |
Holoprosencephaly-7 (HPE7) | PTCH1+del |
Holt-Oram syndrome (HOS) (HOS1) | TBX5+del+dup |
Humerospinal Dysostosis, HSD | CHST3 (=C6ST1) |
Hurthle cell thyroid carcinoma (HCTC) | HRAS |
Hutchinson-Gilford progeria syndrome (HGPS) | LMNA+del |
Hydranencephaly with abnormal genitalia | ARX+del+dup |
Hydrolethalus syndrome 2 | KIF7 |
HYP | PHEX+del+dup |
Hypercalciuric rickets | SLC34A3 |
Hyperchylomicronemia, familial | LPL+del+dup |
Hyperekplexia, hereditary 1 (HKPX1) | GLRA1+del |
Hyperinsulinemic hypoglycemia, familial (HHF) | ABCC8+del, KCNJ11 |
Hyperinsulinism, congenital | KCNJ11 |
Hyperkeratosis-contracture syndrome | LMNA+del |
Hyperlipemia | LPL+del+dup |
Hyperlipidemia, familial combined (FCHL) | LPL+del+dup |
Hyperlipoproteinemia | LPL+del+dup, APOC2+del |
Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency | MAT1A |
Hypernephroma | VHL+del |
Hyperostosis corticalis deformans juvenilis | TNFRSF11B (=OPG) |
Hyperostosis corticalis generalis | SOST |
Hyperostosis with Hyperphosphatemia | FGF23 |
Hyperostosis, cortical, with syndactyly | SOST |
Hyperostosis, endosteal, autosomal recessive | SOST |
Hyperostosis-Hyperphosphatemia syndrome (HHS) | FGF23 |
Hyperphenylalaninemia, mild (HPA, mild) | PAH+del |
Hyperphenylalaninemia, non-PKU mild (= HPA) | PAH+del |
Hyperphosphatasemia tarda | SOST |
Hyperphosphatasia | TNFRSF11B (=OPG) |
Hypertelorism with esophageal abnormality and hypospadias | MID1+del+dup |
Hypertelorism-hypospadias syndrome | MID1+del+dup |
Hypertension, salt-resistant (?) | NPR3 |
Hyperthyroidism, familial, due to inappropriate thyrotropin secretion | THRB |
Hyperthyroxinemia, familial euthyroid, secondary to pituitary and peripheral resistance to thyroid hormones | THRB |
Hypertrophic osteoarthropathy, primary, autosomal recessive, 1 (PHOAR1) | HPGD |
Hypochondrogenesis | COL2A1+del |
Hypochondroplasia | FGFR3 |
Hypoglycemia of infancy, leucine-sensitive | ABCC8+del |
Hypogonadism with spermatogenesis | GNRHR |
Hypogonadotropic hypogonadism with or without anosmia (HH) | KAL1, FGFR1 (= KAL2), PROKR2, PROK2, CHD7, FGF8, GNRHR, KISS1R, NSMF (= NELF), TAC3, TACR3, GNRH1, KISS1, WDR11, HS6ST1, SEMA3A, SPRY4, IL17RD, DUSP6, FGF17, FLRT3, NR5A1, PIN1 |
Hypophosphatasia (HOPS) | ALPL (=TNSALP)+del |
Hypophosphatemia | PHEX+del+dup; FGF23 |
Hypophosphatemic rickets | PHEX+del+dup; FGF23 |
Hypophosphatemic rickets with hypercalciuria (HHRH) | SLC34A3 |
Hypophosphatemic Vitamin D-resistant rickets (HPDR) | PHEX+del+dup |
Hypoplastic left heart syndrome 2 (HLHS2) | NKX2-5 |
Hyposplenia, isolated congenital | NKX2-5 |
Hypothalamic hamartoblastoma, hypopituitarism, imperforate anus, and postaxial polydactyly | GLI3+del+dup |
Hypothalamic hamartomas, somatic | GLI3+del+dup |
Hypothyroidism, congenital nongoitrous, 5 (CHNG5) | NKX2-5 |
Hystrix-like ichthyosis with deafness (HID syndrome) | GJB2 (=CX26) |
Krankheit | Gen |
IBIDS syndrome | ERCC3 (=XPB) |
I-cell disease (ICD) | GNPTAB+del+dup |
Ichthyosiform erythroderma with hair abnormality and mental and growth retardation | ERCC3 (=XPB) |
Ichthyosis, congenital, with trichothiodystrophy | ERCC3 (=XPB) |
Idiopathic hypogonadotropic hypogonadism | KAL1, FGFR1 (= KAL2), PROKR2, PROK2, CHD7, FGF8, GNRHR, KISS1R, NSMF (= NELF), TAC3, TACR3, GNRH1, KISS1, WDR11, HS6ST1, SEMA3A, SPRY4, IL17RD, DUSP6, FGF17, FLRT3, NR5A1, PIN1 |
Idiopathic scoliosis 3, susceptibility to (IS3) | CHD7 (=KAL5)+del |
Illig-type growth hormone deficiency | GH1+del+dup |
IMAGE (Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies) syndrome | CDKN1C+dup |
Immunodeficiency, isolated | IKBKG (=NEMO)+del |
Immunodeficiency, severe combined, with hypereosinophilia | DCLRE1C (=ARTEMIS)+del, RAG1+del, RAG2+del |
Immunodeficiency-centromeric instability-facial anomalies syndrome (ICF1) | DNMT3B |
Inclusion cell disease (ICD) | GNPTAB+del+dup |
Incontinentia pigmenti (IP) | IKBKG (=NEMO)+del |
Incontinentia pigmenti, type II, formerly (IP2, formerly) | IKBKG (=NEMO)+del |
Infantile cortical hyperostosis | COL1A1+del |
Infantile epileptic-dyskinetic encephalopathy | ARX+del+dup |
Infantile hemiparesis | COL4A1, COL4A2 |
Infantile spasm syndrome, X-linked (ISSX) | ARX+del+dup, CDKL5+del+dup |
Infantile systemic hyalinosis (ISH) | ANTXR2 (=CMG2) |
Infiltrative fibromatosis, familial (FIF) | APC+del+dup |
Insulin resistance, susceptibility to | PTPN1 |
Interrupted aortic arch | NKX2-5 |
Intervertebral disc disease (IDD), susceptibility to | COL9A2, COL9A3 |
Invasive pneumococcal disease, recurrent isolated, 2 (IPD2) | IKBKG (=NEMO)+del |
Iridogoniodysgenesis (IRID) | PITX2+del |
Iridogoniodysgenesis syndrome (IGDS) | PITX2+del |
Iris hypoplasia and glaucoma | PITX2+del |
Isovaleric acidemia (IVA) | IVD |
Jackson-Weiss syndrome (JWS) | FGFR1+del (=KAL2), FGFR2+del |
Jadassohn nevus phakomatosis (JNP) | KRAS |
Jansen metaphyseal chondrodysplasia (JMC) | PTH1R (= PTHR) |
Jeune syndrome | WDR34, IFT80 |
Joubert syndrome (JBTS) | KIF7, TCTN3 |
JP/HHT syndrome | SMAD4 |
JPS/HHT | SMAD4 |
Juberg-Marsidi syndrome (JMS) | ATRX+del+dup (bei Frauen) |
Juvenile hyaline fibromatosis (JHF) | ANTXR2 (=CMG2) |
Juvenile intestinal polyposis (JIP) | BMPR1A+del |
Juvenile polyposis coli | BMPR1A+del |
Juvenile polyposis of infancy | BMPR1Adel, PTEN+del |
Juvenile polyposis of stomach | BMPR1A+del |
Juvenile polyposis syndrome (JPS) | BMPR1A+del, SMAD4, PTEN+del |
Juvenile polyposis with hereditary telangiectasia | SMAD4 |
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JPHT) | SMAD4 |
Kallmann syndrome (-> Hypogonadotropic hypogonadism) | |
Keller syndrome | MED12 |
Keratitis, hereditary (KERH) | PAX6+del |
Keratitis-ichthyosis-deafness syndrome (KID syndrome) | GJB2 (=CX26) |
Keratoderma, palmoplantar, with deafness (PPKDFN) | GJB2 (=CX26) |
Keratosis palmoplantaris with cystic eyelids, hypodontia, and hypotrichosis | WNT10A |
Keratosis, seborrheic, somatic | FGFR3 |
Kinky hair disease | ATP7A+del+dup |
Klein-Waardenburg syndrome | PAX3+del |
Klippel-Feil syndrome 1, autosomal dominant (KFS1) | GDF6 |
Kniest dysplasia (KD) | COL2A1+del |
Kowarski syndrome (KWKS) | GH1+del+dup |
Krankheit | Gen |
L-2-Hydroxyglutaric acidemia (L2HGA) | L2HGDH+del |
L-2-Hydroxyglutaric aciduria (L2HGA) | L2HGDH+del |
Lacrimoauriculodentodigital syndrome (LADDS) | FGFR3, FGF10+del, FGFR2+del |
LADD syndrome (LADDS) | FGFR3, FGF10+del, FGFR2+del |
Lamb syndrome | PRKAR1A+del |
Langer mesomelic dysplasia (LMD) | SHOX+del |
Langer-Giedion syndrome (LGS) | EXT1+del (=TRPS2), TRPS1del |
Larsen syndrome (LRS), autosomal dominant | FLNB |
Larsen syndrome, autosomal recessive | CHST3 (=C6ST1) |
Lateral cleft, isolated | PTCH2 |
Lateral incisors, absence of | WNT10A |
Lateral incisors, pegged or missing | WNT10A |
Legg-Calve-Perthes disease (LCPD; LCP) | COL2A1+del |
Leigh syndrome due to pyruvate carboxylase deficiency | PC |
Leiomatosis, diffuse, with Alport syndrome (DL-ATS) | COL4A5+del |
Leiomatosis, esophageal and vulval, with nephropathy | COL4A5+del |
Leiomyoma, uterine, somatic (UL) | HMGA2 |
Lentiginosis, cardiomyopathic | PTPN11+del+dup, RAF1+dup, BRAF |
Lenz microphthalmia syndrome (LMS) | BCOR+del |
LEOPARD syndrome | PTPN11+del+dup, RAF1+dup, BRAF |
Leri-Weill dyschondrosteosis (LWD) | SHOX+del (erst Del dann Seq) |
Lethal short-limbed platyspondylic dwarfism, Torrance type | COL2A1+del |
Leukemia, acute lymphoblastic (ALL) | FLI1, LHX4+del |
Leukemia, acute lymphocytic | FLI1, LHX4+del |
Leukemia, acute myelogenous (AML) | TRIP11, JAK2, CREBBP+del, IDH1, NSD1 (=SOTOS)+del, KIT, KRAS, EP300+del, TERT, GATA2, RUNX1, CEBPA |
Leukemia, acute myeloid | TRIP11, JAK2, CREBBP+del, IDH1, NSD1 (=SOTOS)+del, KIT, KRAS, EP300+del, TERT, GATA2, RUNX1, CEBPA |
Leukemia, acute T-cell lymphoblastic | NOTCH1+del, SETBP1 |
Leukemia, juvenile myelomonocytic (JMML) | NF1+del, PTPN11 |
Leukemia, megakaryoblastic, with or without Down syndrome, somatic | GATA1 |
Leukodystrophy, hypomyelinating, 2 (HLD2) | GJC2 |
Leukoencephalopathy with Axenfeld-Rieger anomaly | COL4A1, COL4A2 |
Levy-Hollister syndrome | FGFR3, FGF10+del, FGFR2+del |
Lhermitte-Duclos syndrome (LDD) | PTEN+del |
Limb/pelvis-hypoplasia/aplasia syndrome (LPHAS) | WNT7A |
Limb-mammary syndrome (LMS) | TP63 (=p63) |
Linear sebaceous nevus syndrome | KRAS |
Lipase D deficiency | LPL+del+dup |
Lipoamide dehydrogenase deficiency, lactic acidosis due to | DLD (=LAD) |
Lipoatrophic diabetes | LMNA+del, BSCL2+del |
Lipocalcinogranulomatosis | FGF23 |
Lipodystrophy, Berardinelli-Seip congenital | BSCL2+del, CAV1, PTRF |
Lipodystrophy, cephalothoracic type | LMNB2 |
Lipodystrophy, congenital generalized (CGL) | AGPAT2+del, BSCL2+del, CAV1, PTRF |
Lipodystrophy, familial partial, Dunnigan type | LMNA+del |
Lipodystrophy, familial partial, type 2 (FPLD2) (FPL2) | LMNA+del |
Lipodystrophy, familial, of limbs and lower trunk | LMNA+del |
Lipodystrophy, partial, acquired, susceptibility to (APLD) (APLD), susceptibility to | LMNB2 |
Lipodystrophy, partial, progressive | LMNB2 |
Lipodystrophy, reverse partial | LMNA+del |
Lipodystrophy, total, and acromegaloid gigantism | BSCL2+del |
Lipodystrophy, type A, associated with mandibuloacral dysplasia | LMNA+del |
Lipoma (LIPO) | HMGA2 |
Lipomatosis of pancreas, congenital | SBDS+del |
Lipomatosis, familial multiple (FML) | HMGA2 |
Lipomatosis, multiple | HMGA2 |
Lipoprotein lipase deficiency | LPL+del+dup |
Lip-pit syndrome (LPS=PIT) | IRF6+del |
Lissencephaly, X-linked 2 (LISX2) | ARX+del+dup |
Lissencephaly, X-linked, with ambiguous genitalia (XLAG) (XLISG) | ARX+del+dup |
Lobular carcinoma in situ (LCIS) | MLH1+del |
Loeys-Dietz syndrome (LDS) | TGFBR1+dup, TGFBR2, SMAD3, TGFB2+del |
Low-birth-weight dwarfism with skeletal dysplasia | RNU4ATAC |
LPL deficiency | LPL+del+dup |
Lujan-Fryns syndrome | MED12 |
Lumbar disc herniation (LDH), susceptibility to | COL11A1+del, MMP9 |
Lung cancer | TP63 (=p63) |
Lung cancer susceptibility 2 (LNCR2) | CHRNA3 |
Lung cancer, non-small cell (NSCLC) | STK11 |
Lung cancer, somatic | KRAS |
Lymphangioleiomyomatosis (LAM) (Lymphangiomatosis) | TSC1+del, TSC2+del |
Lymphedema and yellow nails (LYYN) | FOXC2+del |
Lymphedema with distichiasis (LYD) | FOXC2+del |
Lymphedema, hereditary (LMPH) | GJC2, FOXC2+del |
Lymphedema-distichiasis syndrome (LYDS) | FOXC2+del |
Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus | FOXC2+del |
Lynch syndome | MSH2+del, MLH1+del, PMS2+del, MSH6+del, TGFBR2+del, MLH3 |
Lysosomal glycogen storage disease without acid maltase deficiency, formerly | LAMP2+del |
Krankheit | Gen |
Macrocephaly/autism syndrome (MCEPHAS) | PTEN+del |
Macrostomia, isolated | PTCH2 |
Maffucci syndrome (= Enchondromatosis, multiple, Maffucci type) | IDH1, IDH2 |
Majeed syndrome (MAJEEDS) | LPIN2 |
Male germ cell tumor (MGCT) | KIT |
Male Turner snydrome | PTPN11+dup |
Malignant rhabdoid tumor, somatic (MRT) | SMARCB1 (=INI1)+del |
Malouf syndrome | LMNA+del |
Mandibuloacral dysplasia with type A lipodystrophy (MADA) | LMNA+del |
Mandibuloacral dysplasia with type A lipodystrophy, atypical | LMNA+del |
Mandibulofacial dysostosis (MFD1) | TCOF1+del |
Maple syrup urine disease, type III | DLD (=LAD) |
Marfan syndrome (MFS) | FBN1+del |
Marfan syndrome, atypical | COL1A2+del |
Marfanoid craniosynostosis syndrome | SKI |
Marfanoid disorder with craniosynostosis, type I | SKI |
Marshall syndrome (MARSHS) | COL11A1+del |
Marshall-Smith syndrome (MSS) | NFIX |
MASS syndrome | FBN1+del |
Mast cell disease | KIT |
Mastocytosis | KIT |
Meacham syndrome (MEACHS) | WT1+del |
MECP2 duplication syndrome | MECP2+del |
Medium chain Acyl-CoA dehydrogenase deficiency (MCAD) | ACADM (=MCAD)+del |
Medulloblastoma (MDB) | CTNNB1 |
Medulloblastoma (MDB), somatic | APC+del+dup, PTCH1+del, PTCH2 |
Medulloblastoma with extensive nodularity (MBEN) | SUFU+del |
Medulloblastoma, desmoplastic (MDB, desmoplastic) | SUFU+del |
Meige disease | FOXC2+del |
Meige lymphedema | FOXC2+del |
Melanoma, cutaneous malignant, 9 | TERT |
Melanoma, desmoplastic neurotrophic (DNM) | NF1+del |
Melanoma, malignant sporadic | STK11 |
Melanoma, malignant, somatic | BRAF, PTEN+del |
Meningioma | PTEN+del |
Menkes disease (MK) (MNK) | ATP7A+del+dup |
Menkes syndrome | ATP7A+del+dup |
Mental retardation and muscular atrophy | SLC16A2 (=MCT8)+del |
Mental retardation, autosomal dominant 20 (MRD20) | MEF2C |
Mental retardation, large head, imperforate anus, congenital hypotonia, and partial agenesis of corpus callosum | MED12 |
Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations | MEF2C |
Mental retardation, X-linked 19 (MRX19) | RPS6KA3 (= RSK2) +del+dup |
Mental retardation, X-linked 29/32/33/38/43/54/76/87 | ARX+del+dup |
Mental retardation, X-linked 36 (MRX36) | ARX+del+dup |
Mental retardation, X-linked syndromic 1 (MRXS1) | ARX+del+dup |
Mental retardation, X-linked syndromic 13 (MRXS13) | MECP2+del |
Mental retardation, X-linked syndromic 16 (MRXS16) | FGD1+del |
Mental retardation, X-linked syndromic, Lubs type (MRXSL) | MECP2+del |
Mental retardation, X-linked, with creatine transporter deficiency | SLC6A8+del |
Mental retardation, X-linked, with dystonic movements, ataxia, and seizures | ARX+del+dup |
Mental retardation, X-linked, with growth retardation, deafness, and microgenitalism | ATRX+del+dup |
Mental retardation, X-linked, with hypotonia | SLC16A2 (=MCT8)+del |
Mental retardation, X-linked, with marfanoid habitus | MED12 |
Mental retardation, X-linked, with or without seizures, ARX-related (MRXARX) | ARX+del+dup |
Mental retardation, X-linked, with seizures, short stature, and midface hypoplasia | SLC6A8+del |
Mental retardation-hypotonic facies syndrome, X-linked (MRXHF1) | ATRX+del+dup |
Mesomelic dwarfism of the hypoplastic ulna, fibula, and mandible type | SHOX+del |
Mesothelioma, malignant; susceptibility to (MESOM) | CTNNB1 |
Mesothelioma, somatic (MESOM) | WT1+del |
Metachondromatosis (METCDS) | PTPN11+del+dup |
Metaphyseal anadysplasia (MANDP) | MMP13, MMP9 |
Metaphyseal chondrodysplasia, Jansen type | PTH1R (= PTHR) |
Metaphyseal chondrodysplasia, McKusick type | RMRP |
Metaphyseal chondrodysplasia, Murk Jansen type | PTH1R (= PTHR) |
Metaphyseal chondrodysplasia, Schmid type (MCDS) | COL10A1 |
Metaphyseal chondromatosis with urinary excretion of D-2-hydroxy-glutaric acid (MC-HGA) | IDH1, IDH2 |
Metaphyseal dysplasia without hypotrichosis | RMRP |
Metatropic dwarfism (MD) | TRPV4 |
Metatropic dysplasia (MTD) | TRPV4 |
Methionine adenosyltransferase (MAT) deficiency, autosomal recessive | MAT1A |
Methylmalonic acidemia and homocystinuria, cblC type | MMACHC |
Methylmalonic aciduria and homocystinuria, cblC type | MMACHC |
Methylmalonic aciduria and homocystinuria, Vitamin B12-responsive | MMACHC |
Microcephalic osteodysplastic primordial dwarfism, type I (MOPD1) (MOPD I) (MOPD) | RNU4ATAC |
Microcephalic osteodysplastic primordial dwarfism, type II (MOPD2) | PCNT (=MOPD2)+del |
Microphthalmia | VAX1 |
Microphthalmia and cataract 2 | SIX6 |
Microphthalmia and esophageal atresia syndrome | SOX2+del |
Microphthalmia with brain and digital anomalies | BMP4 |
Microphthalmia, cataract, and nystagmus | SIX6 |
Microphthalmia, isolated 4 (MCOP4) | GDF6 |
Microphthalmia, isolated, with cataract 2 (MCOPCT2) | SIX6 |
Microphthalmia, isolated, with coloboma 6, digenic (MCOPCB6) | GDF6 |
Microphthalmia, syndromic (MCOPS) | BCOR+del, SOX2+del, OTX2+del, BMP4 |
Microvascular complications of diabetes, susceptibility to, 1 (MVCD1) | VEGFA |
Mismatch repair cancer syndrome (MMRCS) | MLH1+del, MSH2+del, MSH6+del, PMS2+del |
Mohr-Majewski syndrome | TCTN3 |
Mohr-Wriedt type brachydactyly | GDF5 (=CDMP1), BMP2+del+dup, BMPR1B |
Monocarboxylate transporter 8 (MCT8) deficiency | SLC16A2 (=MCT8)+del |
Monocytopenia and mycobacterial infection syndrome (MONOMAC) | GATA2 |
Monocytopenia with susceptibility to mycobacterial, fungal, and papillomavirus infections and myelodysplasia | GATA2 |
MonoMAC (monocytopenia, NK- and B- lymphocytopenia, severe infections with M. avium complex (MAC), and risk of progression to MDS/AML) (GATA2 deficiency) | GATA2 |
Morbus Teutschlaender | FGF23 |
Morning glory disc anomaly | PAX6+del |
Morquio A syndrome | GALNS+del |
Morquio syndrome B | GLB1+del+dup |
Motor and sensory neuropathy, hereditary, 4 (HMSN4) | PEX7+del |
Mowat-Wilson syndrome (MWIS) | ZEB2+del |
Moyamoya disease 5 (MYMY5) | ACTA2 |
Muckle-Wells syndrome (MWS) | NLRP3 (=NALP3) |
Mucolipidosis II alpha/beta (ML II) | GNPTAB+del+dup |
Mucolipidosis III alpha/beta (ML III) | GNPTAB+del+dup |
Mucopolysaccharidosis type 4A (MPS4A) | GALNS+del |
Mucopolysaccharidosis type IVB (MPS IVB) (MPS4B) | GLB1+del+dup |
Muenke syndrome | FGFR3 |
Muir-Torre syndrome (MRTES) | MLH1+del, MSH2+del |
Mullerian aplasia and hyperandrogenism (MULLAPL) | WNT4 |
Mullerian duct failure and hyperandrogenism | WNT4 |
Multicentric carpotarsal osteolysis syndrome (MCTO) | MAFB |
Multicentric osteolysis, autosomal dominant | MAFB |
Multicentric osteolysis, nodulosis, and arthropathy (MONA) | MMP14, MMP2 |
Multiple acyl-CoA dehydrogenase deficiency (MADD) | ETFDH, ETFA, ETFB |
Multiple basal cell nevi, odonogenic keratocysts, and skeletal anomalies | PTCH1+del |
Multiple hamartoma syndrome (MHAM) | PTEN+del |
Multiple lentigines syndrome | PTPN11+del+dup, RAF1+dup, BRAF |
Multiple lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormal genitalia, retardation of growth, and sensorineural deafness (LEOPARD) | PTPN11+del+dup, RAF1+dup, BRAF |
Multiple myeloma (MM) | FGFR3 |
Multiple self-healing squamous epithelioma, susceptiblity to (MSSE) | TGFBR1+dup |
Multiple synostoses syndrome (SYNS) | NOG, GDF5 (=CDMP1), FGF9 |
Multisystem inflammatory disease, neonatal onset (NOMID) | NLRP3 (=NALP3) |
Multisystemic smooth muscle dysfunction syndrome | ACTA2 |
Muscular dystrophy with early contractures and cardiomyopathy, autosomal dominant | LMNA+del |
Muscular dystrophy, congenital, LMNA-related (MDCL) | LMNA+del |
Muscular dystrophy, limb-girdle, type 1B (LGMD1B) | LMNA+del |
Muscular dystrophy, proximal, type 1B | LMNA+del |
Mycobacterial disease, susceptibility to, X-linked, type 1 | IKBKG (=NEMO)+del |
Myelodysplastic syndrome, susceptibility to | GATA2 |
Myelofibrosis with myeloid metaplasia, somatic (MMM) | MLP (=C-MLP) |
Myelofibrosis, somatic | JAK2 |
Myelokathexis, isolated | CXCR4 |
Myhre syndrome (MYHRS) | SMAD4 |
Myopathy, congenital, with excess of muscle spindles (CMEMS) | HRAS |
Myxoma, intracardiac (INTMYX) | PRKAR1A+del |
Myxoma, spotty pigmentation, and endocrine overactivity | PRKAR1A+del |
Krankheit | Gen |
Naegeli syndrome | KRT14 |
Naegeli-Franceschetti-Jadassohn syndrome (NFJS) | KRT14 |
Nail-patella syndrome (NPS) | LMX1B+del |
Nail-patella syndrome with primary open angle glaucoma (POAG) | LMX1B+del |
Najjar syndrome | LMNA+del |
Name syndrome | PRKAR1A+del |
Nance-Insley syndrome | COL2A1+del, COL11A2 |
Nance-Sweeney chondrodysplasia | COL2A1+del, COL11A2 |
Navajo brainstem syndrome | HOXA1 |
Neck cancer | TP63 (=p63) |
Nemaline myopathy 4 (NEM4) | TPM2 |
Nephroblastoma | WT1+del |
Nephrolithiasis/osteoporosis, hypophosphatemic, 1 (NPHLOP1) | SLC34A1 |
Nephropathy, Wilms tumor, and genital anomalities | WT1+del |
Nephrotic syndrome, type 4 (NPHS4) | WT1+del |
Nesidioblastosis | KCNJ11 |
Netherton disease | SPINK5 |
Netherton syndrome (NETH) (NS) | SPINK5 |
Neurilemmomatosis, congenital cutaneous | SMARCB1 (=INI1)+del |
Neurofibromatosis | NF1+del, SMARCB1 (=INI1)+del |
Neurofibromatosis, type I, with leukemia (DD zu MMRCS) | MSH2+del |
Neurofibromatosis-Noonan syndrome (NFNS) | NF1+del |
Neuronopathy, distal hereditary motor, type V (HMN5) | BSCL2+del |
Neuronopathy, distal hereditary motor, type VA (HMN5A) (HMN VA) | BSCL2+del |
Neuropathy, distal hereditary motor, type VA (DHMN5A) (DHMN VA) | BSCL2+del |
Neuropathy, hereditary sensory, type ID (HSN1D) | ATL1+del |
Nevo syndrome | PLOD1+del+dup |
Nevoid basal cell carcinoma syndrome (NBCCS) | PTCH1+del |
Nevus sebaceous of Jadassohn | KRAS |
Nevus, keratinocytic, nonepidermolytic (KNEN) | FGFR3 |
Nodulosis-arthropathy-osteolysis (NAO) syndrome | MMP14, MMP2 |
Nonproliferative retinopathy, diabetic, susceptibility to | VEGFA |
Nonsmall cell lung cancer, somatic | BRAF |
Noonan syndrome | PTPN11+dup, RAF1+del+dup, SOS1, RIT1, KRAS, MAP2K1, BRAF |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSL) | CBL |
Noonan-Neurofibromatosis syndrome | NF1+del |
Obesity, adrenal insufficiency, and red hair | POMC |
Obesity, autosomal dominant (OBESITY) | MC4R |
Obesity, early-onset, susceptibility to | POMC |
Obesity, morbide | CEP19 |
Occipital horn syndrome (OHS) | ATP7A+del+dup |
Ocular coloboma | GDF6 |
Oculoauriculovertebral dysplasia (OAVD) | TCOF1+del |
Oculoauriculovertebral spectrum (OAVS) | TCOF1+del |
Oculofaciocardiodental (OFCD) syndrome | BCOR+del |
O'Donnell-Papas syndrome | PAX6+del |
Odontochondrodysplasia | N.N. |
Odontohypophosphatasia | ALPL (=TNSALP)+del |
Odontoonychodermal dysplasia (OODD) | WNT10A |
OFD syndrome | TCTN3 |
Ohdo syndrome, X-linked (OHDOX) | MED12 |
Ohtahara syndrome, X-linked | ARX+del+dup |
Oligodendroglioma | PTEN+del |
Ollier disease | IDH1, IDH2, PTH1R (= PTHR) |
Omenn syndrome (OS) | DCLRE1C (=ARTEMIS)+del, RAG1+del, RAG2+del |
Ommunodeficiency NEMO-related without anhidrotic ectodermal dysplasia (NEMOID) | IKBKG (=NEMO)+del |
Ondine curse | EDN3 |
Onychoosteodysplasia | LMX1B+del |
Opitz BBBG syndrome, type 1 (BBBG1) | MID1+del+dup |
Opitz GBBB syndrome, type I (GGGB1) | MID1+del+dup |
Opitz GBBB syndrome, X-linked | MID1+del+dup |
Opitz syndrome (OS) | MID1+del+dup |
Opitz syndrome, X-linked (OSX) | MID1+del+dup |
Opitz trigonocephaly syndrome | CD96 |
Opitz trigonocephaly-like syndrome | CD96 |
Opitz-G syndrome, type 1 (OGS1) | MID1+del+dup |
Opitz-Kaveggia syndrome (OKS) | MED12 |
Optic nerve aplasia, bilateral (BONA) | PAX6+del |
Optic nerve coloboma with renal disease | PAX2+del |
Optic nerve head pits, bilateral, congenital | PAX6+del |
Optic nerve hypoplasia and abnormalities of the central nervous system | SOX2+del |
Optic nerve hypoplasia, bilateral (BONH) | PAX6+del |
Oral-facial-digital syndrome, type IV | TCTN3 |
Organoid nevus phakomatosis | KRAS |
Orofacial cleft 6, susceptibility to (OFC6) | IRF6+del, TP63 (=p63), BMP4 |
Orofaciodigital syndrome IV (OFD4) (OFDS IV) | TCTN3 |
OSMED, heterozygous (WZS) | COL11A2 |
Osteoarthritis of distal interphalangeal joints (OADIP) | MATN3 |
Osteoarthritis with mild chondrodysplasia (OACD) | COL2A1+del |
Osteoarthritis, familial early-onset (FOA), susceptibility to | IDH1 |
Osteoarthritis, hand, (HOA) | MATN3 |
Osteoarthritis, susceptibility (OS) | GDF5 (=CDMP1), MATN3 |
Osteochondritis dissecans, short stature, and early-onset osteoarthritis (OD) | ACAN |
Osteochondromas, multiple | EXT1+del (=TRPS2), EXT2+del |
Osteochondromatosis | IDH1, IDH2, PTH1R (= PTHR) |
Osteodysplastic primordial dwarfism, type I | RNU4ATAC |
Osteodysplastic primordial dwarfism, type II | PCNT (=MOPD2)+del |
Osteoectasia, familial | TNFRSF11B (=OPG) |
Osteogenesis imperfecta (OI), autosomal recessive | SERPINF1, CRTAP, LEPRE1+del, PPIB, SERPINH1, FKBP10, SP7, BMP1, TMEM38B+del, WNT1, CREB3L1, PLOD2 |
Osteogenesis imperfecta (OI), autsomal dominant | COL1A1+del, COL1A2+del, IFITM5 |
Osteogenesis imperfecta with congenital joint contractures | PLOD2 |
Osteoglophonic dysplasia (OGD) | FGFR1+del (=KAL2) |
Osteolysis, hereditary multicentric | MMP14, MMP2 |
Osteolysis, hereditary, of carpal bones with or without nephropathy | MAFB |
Osteomalacia, tumor-induced | FGF23 |
Osteonecrosis of femoral head | COL2A1+del |
Osteoporosis, postmenopausal | COL1A2+del |
Osteoporosis, susceptibility to (OSTEOP) | COL1A1+del |
Otospondylomegaepiphyseal dysplasia (OSMED) | COL2A1+del, COL11A2 |
Ovarian cancer (OC) | TP63 (= p63), CTNNB1 |
Ovarian cancer, endometrioid type | MSH6+del |
Ovarian cancer, somatic (OC) | AKT1 |
Overlap connective tissue disease (OCTD) | FBN1+del |
Ovotesticular disorder of sex development | SRY |
Ovotesticular DSD | SRY |
Oxycephaly | TWIST1+del |
Krankheit | Gen |
Pachydermoperiostosis (PDP), autosomal recessive | HPGD |
Paget disease, juvenile (JPD) | TNFRSF11B (=OPG) |
PAH deficiency | PAH+del |
Pallister-Hall syndrome (PHS) | GLI3+del+dup |
Pancreatic cancer (PNCA) | SMAD4 |
Pancreatic cancer, somatic (= Pancreatic carcinoma) | KRAS |
Pancreatic cancer, sporadic | STK11 |
Pancreatic insufficiency and bone marrow dysfunction | SBDS+del |
Pancreatitis, chronic | PRSS1 |
Pancreatitis, hereditary (PCTT) (HPC) (HP) | PRSS1 |
Panhypopituitarism | PROP1+del |
Papillorenal syndrome | PAX2+del |
Parastremmatic dwarfism (PSTD) | TRPV4 |
Parietal foramina 1 (PFM1) | MSX2+del, ALX4 |
Paris-Trousseau thrombocytopenia (TCPT) | FLI1 |
Partington syndrome | ARX+del+dup |
Partington X-linked mental retardation syndrome (PRTS) | ARX+del+dup |
PC deficiency | PC |
Pearson | long range PCRs an mitochondrialer DNA |
Pelizaeus-Merzenbacher-like disease, 1 (PMLD1) | GJC2 |
Pelviscapular dysplasia | TBX15 |
Pendred syndrome (PDS) | FOXI1 |
Perrault syndrome (PRS) | HSD17B4+del (= DBP) |
Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) | KCNJ11 |
Persistent truncus arteriosus (PTA) | NKX2-5 |
Peters anomaly (PAN) | PAX6+del, PITX2+del |
Peters-plus syndrome (PpS) | B3GALTL+del |
Peutz-Jeghers syndrome (PJS) | STK11+del |
Pfeiffer syndrome (PS) | FGFR1+del (=KAL2), FGFR2+del |
Phenylketonuria (PKU) | PAH+del |
Pheochromocytoma | VHL+del |
PHO, autosomal recessive | HPGD |
Phytanic acid oxidase deficiency | PEX7+del |
Piebald trait (PBT) | KIT+del, SNAI2+del |
Piebaldism | KIT+del, SNAI2+del |
Pigmented micronodular adrenocortical disease, primary, 1 | PRKAR1A+del |
Pigmented nodular adrenocortical disease, primary, 1 (PPNAD1) | PRKAR1A+del |
Pilomatricoma (PTR) | CTNNB1 |
Pitt-Hopkins-like syndrome 2 (PTHSL2) | NRXN1+del |
Pituitary dwarfism | GH1+del+dup, PROP1+del |
Pituitary hormone deficiency, combined (CPHD) | POU1F1+del, PROP1+del, LHX3+del, LHX4+del, HESX1+del, OTX2+del |
Pituitary hormone deficiency, combined, with rigid cervical spine or sensorineural deafness with pituitary dwarfism | LHX3+del |
Platelet disorder, familial, with associated myeloid malignancy (FPDMM) | RUNX1 |
Platyspondylic lethal skeletal dysplasia Sand Diego type (PLSD-SD) | FGFR3 |
Platyspondylic lethal skeletal dysplasia, Luton type (PLSD-L) | COL2A1+del |
Platyspondylic skeletal dysplasia, Torrance type (PLSD-T) | COL2A1+del |
Poikiloderma with neutropenia (PN) | USB1 (= C16orf57) |
Poikiloderma with neutropenia, Clericuzio-type | USB1 (= C16orf57) |
Polycythemia rubra vera (PRV) | JAK2 |
Polycythemia vera (PV) | JAK2 |
Polycythemia, Chuvash type | VHL+del |
Polycythemia, VHL-dependent | VHL+del |
Polydactyly with neonatal chondrodystrophy, type III | WDR34 |
Polydactyly, postaxial and preaxial | GLI3+del+dup |
Polyposis syndrome, hereditary mixed, 2 (HMPS2) | BMPR1A+del |
Polyposis, familial, of enire gastrointestinal tract | BMPR1A+del, SMAD4 |
Polyposis, generalized juvenile, with pulmonary arteriovenous malformation | SMAD4 |
Polyposis, hamartomatous intestinal | STK11+del |
Polyposis, juvenile intestinal (PJI) | BMPR1A+del, SMAD4 |
Polyps-and-spots syndrome | STK11+del |
Polysyndactyly with peculiar skull shape | GLI3+del+dup |
Polysyndactyly, uncomplicated | GLI3+del+dup |
Popliteal pterygium syndrome 1 (PPS) | IRF6+del |
POR deficiency | POR+del |
Porencephaly, familial (PCEPH) | COL4A1 |
Porencephaly, type 1, autosomal dominant (ADT1P) | COL4A1 |
Postaxial polydactyly, type A (PAPA) | GLI3+del+dup |
Posterior openbite, familial | PTH1R (= PTHR) |
Potocki-Shaffer syndrome (PSS) | EXT2+del, ALX4 |
Prader-Willi syndrome (PWS) | Deletions-/Duplikations- und Methylierungsanalyse der PWS-kritischen Region in 15q11-q13 (insbesondere SNRPN-Gen) |
Precocious puberty, central | KISS1R |
Premature ovarian failure | FOXL2+del+dup, NR5A1 |
Preterm premature rupture of the membranes, susceptibility to (PPROM) | SERPINH1 |
Primary failure of eruption, nonsyndromic | PTH1R (= PTHR) |
Primary retention of teeth | PTH1R (= PTHR) |
Primordial dwarfism | GH1+del+dup |
Progeria | LMNA+del |
Progeria syndrome, childhood onset | LMNA+del |
Progressive pseudorheumatoid dysplasia (PPD) | WISP3 |
Progressive pseudorheumatoid dysplasia with hypoplastic toes | COL2A1+del |
Proliferative retinopathy, diabetic, susceptibility to | VEGFA |
Proopiomelanocortin deficiency | POMC |
Prostate cancer, somatic (PC) | PTEN+del |
Proteus syndrome (PROTEUSS) | AKT1, PTEN+del |
Proteus-like syndrome | PTEN+del |
Proud syndrome | ARX+del+dup |
Proximal 11p Deletion Syndrome (P11pDS) | EXT2+del, ALX4 |
Pseudoachondroplasia (PSACH) | COMP+del, COL9A3 |
Pseudoglycogenosis II | LAMP2+del |
Pseudo-Hurler polydystrophy | GNPTAB+del+dup |
Pseudo-Morquio syndrome, type 2 | TRPV4 |
Pseudorheumatoid dysplasia, progressive (PPD) | WISP3 |
Pseudorheumatoid dysplasia, progressive, with hypoplastic toes | COL2A1+del |
Pseudoxanthoma elasticum (PXE), modifier of severity of | XYLT1 |
PTEN hamartoma tumor syndrome (PHTS) (includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), Proteus syndrome (PS), and Proteus-like syndrome) | PTEN+del |
Pterygium colli syndrome | PTPN11 |
Pulmonary fibrosis, idiopathic, susceptibility to (IPF) | TERC+del,TERT+del |
Pulmonary fibrosis, telomere-related, 1 | TERT |
Pulmonary hypertension, primary, 3 (PPH3) | CAV1 |
Pulmonic stenosis with cafe-au-lait spots | NF1+del |
Puretic Syndrome | ANTXR2 (=CMG2) |
Pycnodysostosis (PKND) | CTSK |
Pyruvate carboxylase (PC) deficiency | PC |
Krankheit | Gen |
Radioulnar synostosis with amegakaryocytic thrombocytopenia | HOXA11 |
Rapp-Hodgkin syndrome (RHS) | TP63 (=p63) |
Rear syndrome | SALL1+del |
Refetoff syndrome | THRB |
Refsum disease, adult (RDA) / classic | PEX7+del |
Renal cell carcinoma, somatic (RCC) | VHL+del |
Renal glucosuria (GLYS1) | SLC5A2+del |
Renal hypoplasia, isolated | PAX2+del |
Renal-coloboma syndrome | PAX2+del |
Renal-ear-anal-radial syndrome | SALL1+del |
Restrictive dermopathy, lethal | LMNA+del |
Reticuloendotheliosis, familial, with eosinophilia | DCLRE1C (=ARTEMIS)+del, RAG1+del, RAG2+del |
Retinal arteriolar tortuosity, infantile | COL4A1, COL4A2 |
Retinal detachment, rhegmatogenous, autosomal dominant (DRRD) | COL2A1+del |
Retinal dystrophy, early-onset, and pituitary dysfunction | OTX2+del |
Retinopathy, exudative. with bone marrow failure (ERBMF) | TINF2 |
Rett syndrome (RTT; RTS) | MECP2+del |
Rett syndrome, atypical, CDKL5-related | CDKL5+del+dup, FOXG1+del |
Revesz syndrome | TINF2 |
Rhabdoid predisposition syndrome 1 (RPS1) | SMARCB1 (=INI1)+del |
Rhabdoid tumor (RDT) | SMARCB1 (=INI1)+del |
Rhabdoid tumor predisposition syndrome (RTPS) | SMARCB1 (=INI1)+del, SMARCA4 |
Rhabdomyosarcoma 2 (RMS2) | PAX3+del |
Rhabdomyosarcoma, alveolar (RMSA) | PAX3+del |
Rhegmatogenous retinal detachment, autosomal dominant (DRRD) | COL2A1+del |
Rhizomelic chondrodysplasia punctata, type 1 (RCDP1) | PEX7+del |
Riley-Smith syndrome | PTEN+del |
Ring dermoid of cornea (RDC) | PITX2+del |
Rubinstein-Taybi syndrome (RSTS) | CREBBP+del, EP300+del |
Ruvalcaba-Myhre-Smith syndrome (RMSS) | PTEN+del |
Krankheit | Gen |
Saethre-Chotzen syndrome (SCS) | FGFR2+del, TWIST1+del |
Saethre-Chotzen syndrome with eyelid anomalies | TWIST1+del |
Scalp-ear-nipple syndrome (SENS) | KCTD1 |
Scaphocephaly | TWIST1+del |
Scaphocephaly and Axenfeld-Rieger anomaly | FGFR2+del |
Scaphocephaly syndrome, familial (FSPC) | FGFR2+del |
Scaphocephaly, maxillary retrusion, and mental retardation | FGFR2+del |
Scapuloilioperoneal atrophy with cardiopathy | LMNA+del |
Scapuloperoneal spinal muscular atrophy (SPSMA) | TRPV4 |
Schimmelpfennig-Feuerstein-Mims syndrome (SFM), somatic mosaic | KRAS |
Schinzel phocomelia syndrome | WNT7A |
Schinzel-Giedion midface retraction syndrome (SGS) | SETBP1 |
Schizophrenia, susceptibility to | AKT1, NRXN1del |
Schmid-type metaphyseal chondrodysplasia (SMCD) | COL10A1 |
Schöpf-Schulz-Passarge syndrome (SSPS) | WNT10A |
Schwannomatosis | SMARCB1 (=INI1)+del |
Schwartz-Jampel syndrome (SJS) | HSPG2+del, LIFR |
Sclerosteosis 1 (SOST1) (SOST) | SOST |
Scoliosis, congenital, with unilateral unsegmented bar | FLNB |
Sebaceous nevus syndrome, linear | KRAS |
Seckel syndrome | PCNT (=MOPD2)+del |
SED congenita | COL2A1+del |
SED tarda, X-linked | TRAPPC2 (= SEDLIN)+del |
SED, Maroteaux type | TRPV4 |
SED, Namaqualand type | COL2A1+del |
Seip syndrome | BSCL2+del |
SEN syndrome | KCTD1 |
Sensenbrenner syndrome | IFT122, WDR35+del, IFT43 |
Septooptic dysplasia | HESX1+del |
SERKAL syndrome | WNT4 |
severe combined immunodeficiency Athabaskan-type (SCIDA) | DCLRE1C (= ARTEMIS)+del |
severe combined immunodeficiency with sensitivity to ionizing radiation (RS-SCID) | DCLRE1C (= ARTEMIS)+del |
Severe combined immunodeficiency, autosomal recessive, T-cell-negative, B-cell-negative, NK-cell-positive (T-B-NK+ SCID) | RAG1+del, RAG2+del |
Severe combined immunodeficiency, B cell-negative (= B- SCID) | RAG1+del, RAG2+del |
Sex reversal, XY, with or without adrenal failure | NR5A1 |
Sex-reversing locus on X (SRVX), formerly) | SRY |
Sexual ateleiotic dwarfism | GH1+del+dup |
SFM syndrome | KRAS |
Sheldon-Hall syndrome (SHS) | TNNT3, TNNI2, MYH3, TPM2 |
Short rib-polydactyly syndrome (SRPS) | DYNC2H1, WDR34, WDR35+del, WDR60 |
Short stature syndrome, autosomal recessive, with intellectual disability | XYLT1 |
Short stature, idiopathic, X-linked (ISS) | SHOX+del |
Short stature, pituitary and cerebellar defects, and small sella turcica | LHX4+del |
Shprintzen-Goldberg craniosynostosis syndrome (SGS) | SKI |
Shwachman-Bodian syndrome (SBS) | SBDS+del |
Shwachman-Bodian-Diamond syndrome (SBDS) | SBDS+del |
Shwachman-Diamond syndrome (SDS) | SBDS+del |
Silver snydrome | BSCL2+del |
Silver spastic paraplegia syndrome | BSCL2+del |
Silver-Russel syndrome | Deletions-/Duplikations- und Methylierungsanalyse der differentiell methylierten Regionen KvDMR (u.a. KCNQ1-Gen) und H19DMR (u.a. H19-Gen) sowie des CDKN1C-Gens in der SRS-kritischen Region in 11p15; maternal uniparental disomy of chromosome 7; CDKN1C-Seq |
Simpson dysmorphia syndrome (SDYS) | GPC3+del, GPC4del+dup |
Simpson-Golabi-Behmel syndrome, type 1 (SGBS1) (SGBS) | GPC3+del, GPC4del+dup |
SMD, Kozlowski type | TRPV4 |
Smith-Fineman-Myers syndrome type 1 (SFM1) | ATRX+del+dup |
Smith-Lemli-Opitz syndrome (SLOS) | DHCR7+del |
Smith-McCort dysplasia (SMC) | DYM+dup |
Sotos syndrome (SOTOSS) | NSD1 (=SOTOS)+del, NFIX |
Spastic paraplegia with amyotrophy of hands and feet | BSCL2+del |
Spastic paraplegia, autosomal dominant (SPG) | ATL1+del, SPAST, BSCL2+del |
Spastic paraplegia, autosomal recessive (SPG) | CYP7B1, SPG7 (=PGN)+del, GJC2 |
Spermatocytic seminoma, somatic | FGFR3 |
Spermatogenic failure 8 (SPGF8) | NR5A1 |
Spinal muscular atrophy, congenital | TRPV4 |
Spinal muscular atrophy, distal (DSMA) | BSCL2+del, TRPV4 |
Spinal muscular atrophy, distal, X-linked (SMAX) | ATP7A+del+dup |
Splenic hypoplasia | NKX2-5 |
Split-hand/foot malformation (SHFM) | TP63 (=p63), WNT10B |
Spondylism, congenital | FLNB |
Spondylocarpotarsal syndrome | FLNB |
Spondylocarpotarsal synostosis syndrome (SCT) | FLNB |
Spondylocostal dysostosis, autosomal dominant (SCDO) | TBX6+dup |
Spondylocostal dysostosis, autosomal recessive (SCDO) | DLL3, MESP2, LFNG, HES7 |
Spondylodysplasia and premature pubarche | PAPSS2 |
Spondyloenchondrodysplasia with D-2-hydroxyglutaric aciduria
| IDH1, IDH2 |
Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) | ACP5 |
Spondyloepimetaphyseal dysplasia (SEDM), aggrecan type | ACAN |
Spondyloepimetaphyseal dysplasia (SEMD) | MATN3 |
Spondyloepimetaphyseal dysplasia with joint laxity (SEMDJL) | B3GALT6, KIF22 |
Spondyloepimetaphyseal dysplasia with multiple dislocations, Hall type | KIF22 |
Spondyloepimetaphyseal dysplasia, Missouri type (SEMD-MO) | MMP13 |
Spondyloepimetaphyseal dysplasia, Pakistani type (SEMD, PA) | PAPSS2 |
Spondyloepimetaphyseal dysplasia, Strudwick type (SEMD-STR) | COL2A1+del |
Spondyloepiphyseal dysplasia congenita (SEDC) | COL2A1+del |
Spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA) | WISP3 |
Spondyloepiphyseal dysplasia tarda, X-linked (SEDT) | TRAPPC2 (= SEDLIN)+del |
Spondyloepiphyseal dysplasia with congenital joint dislocations | CHST3 (=C6ST1) |
Spondyloepiphyseal dysplasia with precocious osteoarthritis | COL2A1+del |
Spondyloepiphyseal dysplasia, congenital type | COL2A1+del |
Spondyloepiphyseal dysplasia, Kimberley type (SEDK) | ACAN |
Spondyloepiphyseal dysplasia, late | TRAPPC2 (= SEDLIN)+del |
Spondyloepiphyseal dysplasia, Maroteaux type (SEDM) | TRPV4 |
Spondyloepiphyseal dysplasia, Omani type | CHST3 (=C6ST1) |
Spondylohumerofemoral hypoplasia | FLNB |
Spondylometaepiphyseal dysplasia, anauxetic type | RMRP, POP1 |
Spondylometaepiphyseal dysplasia, Menger type | RMRP, POP1 |
Spondylometaphyseal chondrodysplasia, japanese type (SMD) | COL10A1 |
Spondylometaphyseal dysplasia (SMD) | COL2A1+del |
Spondylometaphyseal dysplasia with dentinogenesis imperfecta | N.N. |
Spondylometaphyseal dysplasia, Kozlowski type (SMDK) | TRPV4 |
Spondyloperipheral dysplasia (SPD) | COL2A1+del |
Squamous cell carcinoma, head and neck, somatic (HNSCC) | PTEN+del |
St. Helena dysplasia | NPR2 |
Stapes ankylosis with broad thumb and toes (SABTS) | NOG |
Steely hair disease | ATP7A+del+dup |
Stickler sydrome | COL2A1+del, COL11A1+del, COL11A2, COL9A1, COL9A2 |
Stickler syndrome, atypical | COL2A1+del |
Stickler syndrome, vitreous type | COL2A1+del, COL11A1+del |
Stiff skin syndrome (SSKS) | FBN1+del |
Strudwick syndrome | COL2A1+del |
Strumpell disease | ATL1+del |
Strumpell-Lorrain syndrome | ATL1+del |
Stub thumb | HOXD13+del |
Stueve-Wiedemann syndrome (SWS) | LIFR |
Succedaneous teeth, agenesis of | WNT10A |
Sugio-Kajii syndrome | TRPS1+del |
Supravalvar aortic stenosis (SVAS) | ELN+del |
Supravalvar aortic stenosis, Eisenberg type | ELN+del |
Swyer syndrome | SRY |
Symphalangism, proximal (SYM) | GDF5 (=CDMP1), NOG |
Symphalangism-brachydactyly syndrome | NOG |
Syndactyly with metacarpal and metatarsal fusion | HOXD13+del |
Syndactyly, type 2 (SDTY2) | HOXD13+del |
Syndactyly, type V (SDTY5) | HOXD13+del |
Synostoses, multiple, with brachydactyly | NOG |
Synostosis of talus and calcaneus with short stature | NOG |
Synpolydactyly 1 (SPD1) | HOXD13+del |
Synpolydactyly with foot anomalies | HOXD13+del |
Systemic juvenile hyalinosis | ANTXR2 (=CMG2) |
Krankheit | Gen |
T3 resistance | SLC16A2 (=MCT8)+del |
Tarsal-carpal coalition syndrome (TCC) | NOG |
Tay syndrome | ERCC3 (=XPB) |
Taybi-Linder syndrome (TALS) | RNU4ATAC |
Telangiectasia, hereditary hemorrhagic, with juvenile polyposis coli | SMAD4 |
Telecanthus-hypospadias syndrome | MID1+del+dup |
Temple-Syndrom (maternale uniparentale Disomie des Chromosoms 14) | u.a. MEG3 |
Teratoid tumor, atypical | SMARCB1 (=INI1)+del |
Testicular germ cell tumor (TGCT) | STK11, KIT |
Testicular tumor, sporadic | STK11 |
Testis-determining factor, X-chromosomal (TDFX), formerly | SRY |
Tetralogy of Fallot (TOF) | JAG1+del+dup, NKX2-5, GATA4+del |
Teunissen-Cremers syndrome | NOG |
Teutschlaender disease, familial | FGF23 |
Thanatophoric dwarfism | FGFR3 |
Thanatophoric dysplasia, Luton variant | COL2A1+del |
Thanatophoric dysplasia, Torrance variant | COL2A1+del |
Thanatophoric dysplasia, type I (TD1) | FGFR3 |
Thanatophoric dysplasia, type II | FGFR3 |
Thin membrane nephropathy (TMN) | COL4A3, COL4A4 |
Thin-basement-mambrane nephropathy | COL4A3, COL4A4 |
Thrombocythemia (THCYT) | MLP (=C-MLP), JAK2 |
Thrombocytopenia with beta-thalassemia, X-linked (XLTT) | GATA1 |
Thrombocytopenia, amegakaryocytic, with radioulnar synostosis | HOXA11 |
Thrombocytopenia, congenital amegakaryocytic (CAMT) | MLP (=C-MLP) |
Thrombocytopenia, familial, with propensity to acute myelogenous leukemia | RUNX1 |
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia (XLTDA) | GATA1 |
Thrombocytosis | JAK2 |
Thyroid carcinoma, follicular (FTC), somatic | HRAS, PTEN+del |
Thyroid carcinoma, papillary, somatic (PTC) | PRKAR1A+del |
Thyroid hormone metabolism, abnormal | SECISBP2+del |
Thyroid hormone resistance, generalized (GRTH) (GTHR) | THRB |
Thyroid hormone resistance, selective pituitary (PRTH) | THRB |
Thyroid hormone unresponsiveness | THRB |
Tight skin contracture syndrome, lethal | LMNA+del |
Tooth agenesis, selective, 4 (STHAG4) | WNT10A |
Torg syndrome | MMP14, MMP2 |
Torg-Winchester syndrome | MMP14 |
Torg-Winchester syndrome, formerly | MMP2 |
Touraine-Solente-Gole syndrome | HPGD |
Townes-Brocks branchiootorenal-like syndrome | SALL1+del |
Townes-Brocks syndrome (TBS) | SALL1+del |
Transverse cleft, isolated | PTCH2 |
Treacher Collins syndrome (TCS) | TCOF1+del |
Treacher Collins syndrome 1 (TCS1) | TCOF1+del |
Treacher Collins-Franceschetti syndrome (TCOF) | TCOF1+del |
Trichorhinophalangeal syndrome (TRPS) | TRPS1+del, EXT1+del (=TRPS2) |
Trichothiodystrophy with congenital ichthyosis | ERCC3 (=XPB) |
Trichothiodystrophy, photosensitive (TTDP) | ERCC3 (=XPB) |
Trigonocephaly syndrome | CD96 |
Trigonocephaly, nonsyndromic (TRICEPH) | FGFR1+del (=KAL2) |
Triiodothyronine resistance | SLC16A2 (=MCT8)+del |
Truncus arteriosus communis | NKX2-5 |
Trypsinogen deficiency | PRSS1 |
Tuberous sclerosis (TSC) | TSC2+del, TSC1+del |
Tumoral calcinosis, hyperphosphatemic, familial (HFTC) | FGF23 |
Tumoral calcinosis, primary hyperphosphatemic (PHPTC) | FGF23 |
Turcot syndrome | MLH1+del, MSH2+del, MSH6+del, PMS2+del |
Turner phenotype with normal karyotype | PTPN11+dup |
Krankheit | Gen |
Ulna and fibula, absence of, with severe limb deficiency | WNT7A |
Unerupted second primary molar | PTH1R (= PTHR) |
UPD14 | Methylierungsanalyse der Region 14q32.2 (u.a. MEG3-Gen) |
UPD7 | Methylierungsanalyse der Region 7p12.1 und 7q32.2 (u.a. MEST-Gen) |
Urticaria pigmentosa | KIT+del |
Urticaria-deafness-amyloidosis (UDA) syndrome | NLRP3 (=NALP3) |
VACTERL association | HOXD13+del |
Vacuolar cardiomyopathy and myopathy, X-linked | LAMP2+del |
Van Buchem disease (VBCH) | SOST |
Van der Woude syndrome 1 (VWS1) (VDWS) | IRF6+del |
VATERL association with hydrocephalus (VATERL-H) | PTEN+del |
VATERL association with macrocephaly and ventriculomegaly | PTEN+del |
Ventricular septal defect (VSD) | GATA4+del, NKX2-5 |
Verma-Naumoff syndrome | DYNC2H1, WDR34 |
Vertebral anomalies, anal atresia, congenital cardiac disease, tracheoesophageal fistula, renal anomalies, radial dysplasia, and other limb defects with macrocephaly and ventriculomegaly (VATERL) | PTEN+del |
Vertebral defects (V), anal atresia (A), cardiac malformations (C), tracheoesophageal fistula with esophageal atresia (TE), and radial or renal dysplasia (R), limb anomalies (L) (VACTERL) | HOXD13+del |
Vertebral fusion with carpal coalition | FLNB |
Very long chain Acyl-CoA dehydrogenase deficiency | ACADVL (=VLCAD) |
Vitamin B12 metabolic defect with combined deficiency of mathylmalonyl-CoA mutase and homocysteine:methyltetrahydrofolate methyltransferase | MMACHC |
Vitamin D-resistant rickets | PHEX+del+dup, FGF23 |
Vitreoretinopathy with phalangeal epiphyseal dysplasia | COL2A1+del |
Vohwinkel syndrome (VS) | GJB2 (=CX26) |
Von Gierke disease | G6PC |
von Hippel-Lindau syndrome (VHLS) | VHL+del |
Von Recklinghausen disease | NF1+del |
Waardenburg syndrome with dystopia canthorum | PAX3+del, SNAI2del, EDN3 |
Wagner syndrome type 2 (WGN2) | COL2A1+del |
WAGR syndrome | PAX6del, WT1del |
WAGRO syndrome | PAX6del, WT1del |
Walt Disney dwarfism | GORAB (=SCYL1BP1) |
Watson syndrome | NF1+del |
Weaver syndrome (WES) | EZH2, (NSD1) |
Weaver-Smith syndrome (WSS) | EZH2, (NSD1) |
Weill-Marchesani syndrome (WMS) | FBN1+del |
Weissenbacher-Zweymueller syndrome (WZS) | COL11A2 |
West syndrome, X-linked | ARX+del+dup |
Weyers acrodental dysostosis (WAD) | EVC (=EVC1)+del, EVC2+del |
Weyers acrofacial dysostosis | EVC (=EVC1)+del, EVC2+del |
WHIM (Warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome | CXCR4 |
White forelock with malformations | PAX3+del |
Wiedemann-Beckwith syndroms (WBS) | CDKN1C+dup; NSD1 (=SOTOS)+del |
Williams-Beuren syndrome (WBS) | ELNdel |
Wilms tumor and pseudo- or true hermaphroditism | WT1+del |
Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome | PAX6del, WT1del |
Wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome | PAX6del, WT1del |
Wilms tumor, somatic | GPC3 |
Wilms tumor, type 1 (WT1) | WT1+del |
Winchester syndrome (WNCHRS) | MMP14 |
Wolfram syndrome 1 (WFS1) (WFS) | WFS1+del |
Wolfram-like syndrome, autosomal dominant (WFSL) | WFS1+del |
Wrinkly skin syndrome (WSS) | ATP6V0A2+del |
WS4B with Hirschsprung disease | EDN3 |
Xeroderma pigmentosum, group B (XBP) | ERCC3 (=XPB) |
Xeroderma pigmentosum/Cockayne syndrome (XPB/CS) | ERCC3 (=XPB) |
X-linked recessive chondrodysplasia punctata type 1 (CPXR1) | ARSE+del bei Frauen |
XLMR-Hypotonic facies syndrome | ATRX+del+dup (bei Frauen) |
XMESID | ARX+del+dup |
XP, group B (XPBC) | ERCC3 (=XPB) |
XX Male, SRY-positive | SRY |
Yellow nail syndrome (YNS) | FOXC2+del |
Ärztliche Leitung
Frau Prof. Dr. med. Dr. Judith Fischer
MVZ - Humangenetik
Universitätsklinikum Freiburg
Adresse
Robert-Koch-Straße 3
79106 Freiburg
Tel.: +49 (0)761-270-94440
Fax: +49 (0)761-270-94030
PD Dr. Ekkehart Lausch
MVZ - Humangenetik
Universitätsklinikum Freiburg